This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Superficial injury of neck
ST19_SUPERF_INJURY_NECK
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519870 |
1. Apply sex-specific ruleNone |
519870 |
2. Check conditionsNone |
519870 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
858 |
4. Check minimum number of eventsNone |
858 |
5. Include endpointsNone |
858 |
6. Filter based on genotype QC (FinnGen only) |
813 |
Control definitions (FinnGen only)
- Control exclude
- ST19_INJURI_NECK
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- S1
- Name in latin
- Laesio superficialis colli
Similar endpoints
↥List of similar endpoints to
Superficial injury of neck
based on the number of shared cases.
Similar with more cases:
- Injuries to the neck
- Injury, poisoning and certain other consequences of external causes
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 813 | 465 | 348 |
| Unadjusted period prevalence (%) | 0.16 | 0.17 | 0.16 |
| Median age at first event (years) | 39.24 | 36.57 | 42.81 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 858
- Matched controls
- 8580
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
S10.9
ICD-10 Finland
Superficial injury of neck, part unspecified
2115.0
312.4
284
*
S10.0
ICD-10 Finland
Contusion of throat
2048.9
305.2
278
*
S10.1
ICD-10 Finland
Other and unspecified superficial injuries of throat
+∞
198.9
183
*
NA1AD
NOMESCO Finland
Cervical spine CT examination
14.8
170.2
164
135
S10.8
ICD-10 Finland
Superficial injury of other parts of neck
+∞
108.7
102
*
V49.9
ICD-10 Finland
Car occupant [any] injured in unspecified traffic accident
10.7
105.9
123
132
S13.4
ICD-10 Finland
Sprain and strain of cervical spine
11.9
92.2
98
92
S06.0
ICD-10 Finland
Concussion
4.4
67.9
204
564
T74.1
ICD-10 Finland
Physical abuse
9.0
63.0
81
98
Y04.0
ICD-10 Finland
Assault by bodily force by spouse or partner
29.4
62.5
42
15
AA1AD
NOMESCO Finland
CT of head and brain
3.4
57.1
287
1114
T36
ICD-10 Finland
Poisoning by systemic antibiotics
5.4
46.6
99
203
X59
ICD-10 Finland
Exposure to unspecified factor
3.0
43.7
256
1064
Y04.8
ICD-10 Finland
Assault by bodily force by other known person
15.8
40.2
35
23
F32.9
ICD-10 Finland
Depressive episode, unspecified
3.1
39.2
209
819
Y04.9
ICD-10 Finland
Assault by bodily force by unknown person
12.3
38.8
39
33
W22
ICD-10 Finland
Striking against or struck by other object(s)
3.9
38.6
126
362
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.6
37.4
305
1488
S10.7
ICD-10 Finland
Multiple superficial injuries of neck
+∞
36.7
35
*
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
4.1
36.6
111
302
X58
ICD-10 Finland
Exposure to other specified factors
2.9
36.0
217
905
S00.0
ICD-10 Finland
Superficial injury of scalp
7.8
34.7
49
66
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
5.1
34.1
75
158
W52
ICD-10 Finland
Crushed, pushed or stepped on by crowd or human stampede
7.4
33.8
50
71
Y07
ICD-10 Finland
Other maltreatment
10.7
30.8
34
33
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.2
29.1
394
2351
N02AX02
ATC
tramadol; systemic, rectal
2.2
27.8
368
2167
S20.2
ICD-10 Finland
Contusion of thorax
4.2
27.7
78
200
S01.0
ICD-10 Finland
Open wound of scalp
3.7
27.2
93
274
R51.80
ICD-10 Finland
Headache
2.5
27.0
214
1009
W19
ICD-10 Finland
Unspecified fall
3.1
27.0
122
429
M79.6
ICD-10 Finland
Pain in limb
2.1
25.7
412
2592
F10.09
ICD-10 Finland
Alcohol intoxication UNS
6.0
25.6
46
80
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.2
25.4
284
1549
ZXD35
NOMESCO Finland
Usual procedure
5.3
23.1
47
92
S30.0
ICD-10 Finland
Contusion of lower back and pelvis
3.9
22.7
71
196
W17
ICD-10 Finland
Other fall from one level to another
4.0
22.5
66
174
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
5.8
22.3
41
73
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
5.2
22.1
46
92
N03AE01
ATC
clonazepam; systemic
3.9
21.5
66
180
S60.2
ICD-10 Finland
Contusion of other parts of wrist and hand
3.3
21.4
88
291
N07BB01
ATC
disulfiram; oral
3.9
21.3
66
181
P15
ICPC
Chronic alcohol abuse
4.3
20.6
55
135
S00.1
ICD-10 Finland
Contusion of eyelid and periocular area
5.1
20.1
43
88
N05AH04
ATC
quetiapine; oral
2.2
19.9
218
1163
N06AX11
ATC
mirtazapine; oral
2.0
19.6
317
1951
N03AX12
ATC
[U] gabapentin; oral
2.5
19.3
143
646
P19
ICPC
Drug abuse
7.1
19.2
29
42
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
3.2
18.3
76
253
S40.0
ICD-10 Finland
Contusion of shoulder and upper arm
3.4
18.0
69
218
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.4
18.0
143
665
N03AX16
ATC
[U] pregabalin
2.2
18.0
186
966
J01FF01
ATC
clindamycin; systemic
2.0
18.0
239
1366
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.8
17.9
95
363
S80.0
ICD-10 Finland
Contusion of knee
2.7
17.9
101
399
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
5.6
17.7
34
63
M54.5
ICD-10 Finland
Low back pain
1.9
17.7
347
2261
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
17.6
350
2291
N05BA04
ATC
oxazepam; oral
2.0
17.4
243
1412
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
4.4
17.3
44
104
A01
ICPC
Pain general/multiple sites
2.6
17.1
104
426
Y09
ICD-10 Finland
Assault by unspecified means
16.3
17.1
27
17
S30.1
ICD-10 Finland
Contusion of abdominal wall
6.2
16.9
29
48
F10.20
ICD-10 Finland
Alcohol dependence currently independent
4.9
16.7
37
78
N06AB04
ATC
citalopram; systemic
2.1
16.6
182
964
S00.7
ICD-10 Finland
Multiple superficial injuries of head
20.5
16.5
24
12
N02AJ06
ATC
codeine and paracetamol; systemic
1.8
16.2
388
2671
M54.2
ICD-10 Finland
Cervicalgia
2.6
16.1
98
401
N03AG01
ATC
valproic acid; systemic, rectal
3.0
16.0
73
256
N05BA01
ATC
diazepam; systemic, rectal
2.4
16.0
117
523
N02BE01
ATC
paracetamol; systemic, rectal
2.4
15.9
757
6491
M03BX02
ATC
tizanidine; oral
1.8
15.8
531
4038
N02BF02
ATC
pregabalin; oral
3.0
15.8
74
264
X91.0
ICD-10 Finland
Assault by hanging, strangulation and suffocation by spouse or partner
+∞
15.7
15
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.0
15.5
207
1176
XF400
NOMESCO Finland
ECG with 12 standard connections
2.4
15.5
122
563
F60.9
ICD-10 Finland
Personality disorder, unspecified
5.5
15.5
30
56
A02BC02
ATC
pantoprazole; systemic
1.8
15.5
536
4100
Z72.2
ICD-10 Finland
Drug use
12.6
15.4
27
22
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.3
15.2
133
642
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.2
15.1
138
678
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.6
15.1
93
383
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
4.5
15.1
37
85
J45.9
ICD-10 Finland
Asthma, unspecified
2.1
14.9
171
919
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.1
14.7
169
909
PA6AD
NOMESCO Finland
CT of neck arteries
3.9
14.6
43
114
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
3.2
14.5
60
199
R07.4
ICD-10 Finland
Chest pain, unspecified
1.9
14.4
218
1291
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.9
14.3
209
1222
S93.4
ICD-10 Finland
Sprain and strain of ankle
2.1
14.3
148
765
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
6.5
14.2
23
36
F41.09
ICD-10 Finland
UNS Panic Syndrome
3.3
13.9
54
172
N03AX09
ATC
lamotrigine; oral
2.8
13.9
72
271
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.2
13.8
130
646
M03BC01
ATC
orphenadrine (citrate); systemic
1.9
13.8
208
1227
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.2
13.7
122
593
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
4.6
13.6
32
71
Y04.2
ICD-10 Finland
Assault by bodily force by friend
16.5
13.5
21
13
Z71.8
ICD-10 Finland
Other specified counselling
1.8
13.5
334
2290
L12
ICPC
Hand/finger symptom/complaint
2.0
13.5
174
973
R42
ICD-10 Finland
Dizziness and giddiness
2.0
13.2
171
957
M01AB05
ATC
diclofenac; systemic, rectal
1.7
13.2
532
4164
Z72.0
ICD-10 Finland
Tobacco use
4.2
13.1
35
86
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.7
13.1
353
2473
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
2.3
13.0
110
522
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.7
13.0
426
3145
NG4AA
NOMESCO Finland
Lower leg X-ray examination
3.7
13.0
42
119
N06AB10
ATC
escitalopram; oral
1.8
12.9
228
1411
X70
ICD-10 Finland
Intentional self-harm by hanging, strangulation and suffocation
22.9
12.9
18
8
F10.25
ICD-10 Finland
Alcohol dependence continuous use
5.0
12.9
28
58
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.1
12.8
131
672
TPH04
NOMESCO Finland
Cathetrisation of vein
2.0
12.8
174
990
S00.8
ICD-10 Finland
Superficial injury of other parts of head
4.5
12.7
31
71
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.0
12.7
168
946
R20.2
ICD-10 Finland
Paraesthesia of skin
2.5
12.7
81
339
Z2446
NOMESCO Finland
Social worker
2.6
12.7
79
327
P29
ICPC
Psychological sympt/compl other
2.2
12.6
117
578
M25.5
ICD-10 Finland
Pain in joint
1.7
12.5
298
2012
S80.1
ICD-10 Finland
Contusion of other and unspecified parts of lower leg
3.5
12.5
44
132
B18.2
ICD-10 Finland
Chronic viral hepatitis C
4.8
12.4
28
60
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
2.6
12.4
74
300
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
3.3
12.3
46
143
N06AX16
ATC
venlafaxine; oral
2.0
12.1
148
809
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
5.8
12.0
22
39
NG1BG
NOMESCO Finland
Knee and lower leg MRI examination with high intensity magnet
2.9
12.0
57
205
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.7
12.0
485
3757
P01AB01
ATC
metronidazole; oral, rectal
1.7
11.9
322
2243
Z3231
NOMESCO Finland
Registered nurse
1.8
11.9
226
1425
S22.3
ICD-10 Finland
Fracture of rib
2.6
11.9
69
276
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
9.1
11.8
24
27
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.7
11.8
377
2745
N05CF01
ATC
zopiclone; oral
1.8
11.8
233
1488
D10
ICPC
Vomiting
2.4
11.7
86
384
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.6
11.7
67
266
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
1.9
11.7
156
880
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.9
11.6
173
1011
P01
ICPC
Feeling anxious/nervous/tense
1.8
11.6
191
1152
P16
ICPC
Acute alcohol abuse
4.1
11.5
31
77
N02BF01
ATC
gabapentin; oral
2.3
11.4
90
415
W00
ICD-10 Finland
Fall on same level involving ice and snow
2.2
11.4
102
496
N06AB06
ATC
sertraline; oral
2.0
11.4
134
723
UJF30
NOMESCO Finland
Ileoscopy through colon
2.3
11.3
85
384
W10
ICD-10 Finland
Fall on and from stairs and steps
2.9
11.2
53
190
ZXD05
NOMESCO Finland
Urgent procedure
1.7
11.2
259
1726
S00.9
ICD-10 Finland
Superficial injury of head, part unspecified
5.8
11.0
20
35
S09.9
ICD-10 Finland
Unspecified injury of head
5.1
11.0
23
46
S18
ICPC
Laceration/cut
1.6
11.0
363
2648
L17
ICPC
Foot/toe symptom/complaint
1.7
11.0
253
1680
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.7
11.0
538
4329
R74
ICPC
Upper respiratory infection acute
1.6
11.0
371
2723
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
2.6
10.9
66
269
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.2
10.9
92
436
R55
ICD-10 Finland
Syncope and collapse
2.3
10.9
84
383
P76
ICPC
Depressive disorder
2.2
10.9
95
457
R50.9
ICD-10 Finland
Fever, unspecified
1.9
10.8
143
803
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
5.0
10.8
23
47
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
2.4
10.8
75
327
D11
ICPC
Diarrhoea
2.0
10.8
137
759
J01DB01
ATC
cefalexin; oral
1.9
10.7
707
6144
S19.9
ICD-10 Finland
Unspecified injury of neck
21.8
10.7
15
7
S70.0
ICD-10 Finland
Contusion of hip
3.3
10.7
40
125
M54.4
ICD-10 Finland
Lumbago with sciatica
1.9
10.6
160
937
P99
ICPC
Psychological disorders other
3.0
10.6
48
168
S50.0
ICD-10 Finland
Contusion of elbow
3.2
10.5
41
131
WX290
NOMESCO Finland
Other blockage of nerve
1.6
10.5
482
3801
S83.6
ICD-10 Finland
Sprain and strain of other and unspecified parts of knee
2.5
10.4
66
275
N05AX12
ATC
aripiprazole; systemic
2.5
10.4
65
269
S10
ICD-10 Finland
Superficial injury of neck
33.0
10.3
13
*
R56.8
ICD-10 Finland
Other and unspecified convulsions
2.8
10.3
53
199
J46
ICD-10 Finland
Status asthmaticus
3.9
10.3
30
79
N05AH03
ATC
olanzapine; systemic
2.3
10.3
84
393
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.6
10.2
60
241
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.6
10.1
60
243
N05CD07
ATC
temazepam; oral
2.4
10.0
71
312
S89.9
ICD-10 Finland
Unspecified injury of lower leg
3.1
10.0
42
141
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.7
9.9
249
1686
D01
ICPC
Abdominal pain/cramps general
1.9
9.9
131
734
F10.24
ICD-10 Finland
Alcohol depence active use
4.5
9.8
24
55
S63.6
ICD-10 Finland
Sprain and strain of finger(s)
2.6
9.8
57
228
F43.1
ICD-10 Finland
Post-traumatic stress disorder
2.8
9.8
50
187
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
1.9
9.8
140
805
H02AB06
ATC
prednisolone; systemic
1.6
9.7
357
2652
N71.0
ICD-10 Finland
Acute inflammatory disease of uterus
3.0
9.7
43
149
R11
ICD-10 Finland
Nausea and vomiting
2.1
9.7
90
444
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.6
9.6
57
230
K02.1
ICD-10 Finland
Caries of dentine
1.6
9.6
553
4554
V19
ICD-10 Finland
Pedal cyclist injured in other and unspecified transport accidents
3.9
9.6
28
74
S02.20
ICD-10 Finland
Fracture of nasal bones, closed
3.9
9.6
28
74
V49.2
ICD-10 Finland
Unspecified car occupant injured in collision with other and unspecified motor vehicles in nontraffic accident
15.2
9.5
15
10
J01AA02
ATC
doxycycline; systemic
1.6
9.5
581
4850
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.4
9.5
63
269
G44.2
ICD-10 Finland
Tension-type headache
1.9
9.4
133
761
N07BA03
ATC
varenicline; oral
2.7
9.4
51
197
S12.8
ICD-10 Finland
Fracture of other parts of neck
+∞
9.4
9
*
QAB00
NOMESCO Finland
Suture of skin of head or neck
5.0
9.3
20
41
M03BC51
ATC
orphenadrine, combinations; systemic
1.7
9.3
213
1404
N06AX05
ATC
trazodone; oral
3.6
9.3
30
85
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.8
9.2
175
1095
J01MA12
ATC
levofloxacin; systemic
1.9
9.2
124
698
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
3.8
9.2
28
76
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.1
9.2
86
425
C07AA05
ATC
propranolol; systemic
1.7
9.2
192
1235
L01
ICPC
Neck symptom/complaint
1.8
9.2
150
899
WX408
NOMESCO Finland
General anesthesy, balanced
1.7
9.1
195
1261
N06AX21
ATC
duloxetine; oral
2.0
9.1
105
561
Z25
ICPC
Assault/harmful event problem
4.9
9.1
20
42
A04
ICPC
Weakness/tiredness general
1.8
9.1
148
886
NE1AA
NOMESCO Finland
Pelvis X-ray examination
2.6
9.0
52
207
W55
ICD-10 Finland
Bitten or struck by other mammals
2.9
9.0
42
150
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.9
8.9
122
692
S61.8
ICD-10 Finland
Open wound of other parts of wrist and hand
3.2
8.9
34
108
R4110
NOMESCO Finland
Physiotherapy
1.7
8.8
205
1355
L15
ICPC
Knee symptom/complaint
1.7
8.8
196
1282
X78
ICD-10 Finland
Intentional self-harm by sharp object
6.7
8.7
21
32
K10.3
ICD-10 Finland
Alveolitis of jaws
2.4
8.6
58
249
F43.9
ICD-10 Finland
Reaction to severe stress, unspecified
2.8
8.6
43
159
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.2
8.6
72
340
JN3AD
NOMESCO Finland
Abdominal CT examination
2.0
8.6
98
521
N05AA02
ATC
levomepromazine; systemic
2.8
8.6
42
154
A11
ICPC
Chest pain NOS
2.3
8.5
65
295
ZXE00
NOMESCO Finland
One hour or less
1.6
8.5
301
2200
SPAT1263
SPAT
Sampling
1.5
8.5
343
2585
S12.2
ICD-10 Finland
Fracture of other specified cervical vertebra
90.9
8.4
9
*
SFA30
NOMESCO Finland
Three-surface restoration
1.5
8.4
330
2468
S70.1
ICD-10 Finland
Contusion of thigh
3.8
8.4
25
67
SFA10
NOMESCO Finland
One-surface restoration
1.5
8.3
492
4016
N05BE01
ATC
buspirone; oral
3.0
8.3
35
118
L08
ICPC
Shoulder symptom/complaint
1.7
8.3
176
1135
Z01.8
ICD-10 Finland
Other specified special examinations
1.7
8.3
176
1135
R51
ICD-10 Finland
Headache
2.2
8.2
67
313
A46
ICD-10 Finland
Erysipelas
1.9
8.1
101
553
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.2
8.1
71
342
R53
ICD-10 Finland
Malaise and fatigue
1.6
8.1
221
1518
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.7
8.1
175
1133
M01AE03
ATC
ketoprofen; systemic, rectal
1.6
8.1
239
1674
S63.5
ICD-10 Finland
Sprain and strain of wrist
2.5
8.0
50
207
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.2
8.0
68
323
N06AX12
ATC
bupropion; oral
2.0
8.0
91
483
M79.2
ICD-10 Finland
Neuralgia and neuritis, unspecified
3.9
8.0
23
60
P03
ICPC
Feeling depressed
1.8
8.0
129
768
D06
ICPC
Abdominal pain localized other
2.0
8.0
84
434
R07.3
ICD-10 Finland
Other chest pain
2.0
7.9
85
442
M79.1
ICD-10 Finland
Myalgia
1.8
7.9
141
864
J11
ICD-10 Finland
Influenza, virus not identified
4.5
7.9
19
43
J45
ICD-10 Finland
Asthma
2.0
7.9
90
478
P17
ICPC
Tobacco abuse
4.7
7.9
18
39
QCB10
NOMESCO Finland
Major dressing of wound of skin of upper limb
3.6
7.9
25
70
U71
ICPC
Cystitis/urinary infection other
2.3
7.9
58
260
J01MA02
ATC
ciprofloxacin; systemic
1.6
7.8
263
1893
R06.0
ICD-10 Finland
Dyspnoea
1.6
7.8
196
1317
Z71.9
ICD-10 Finland
Counselling, unspecified
2.1
7.8
79
403
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
3.9
7.7
22
57
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
2.0
7.7
84
439
H02AB04
ATC
methylprednisolone; systemic
1.9
7.7
101
563
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.0
7.7
92
497
NC1AA
NOMESCO Finland
Elbow X-ray examination without contrast
2.9
7.7
36
129
M53.1
ICD-10 Finland
Cervicobrachial syndrome
1.8
7.7
112
647
R03AC02
ATC
salbutamol; inhalant
1.5
7.6
460
3742
N01
ICPC
Headache
1.7
7.6
143
890
J20
ICD-10 Finland
Acute bronchitis
2.0
7.6
88
471
WX002
NOMESCO Finland
Sedation and analgesia
1.8
7.6
125
749
SPAT1265
SPAT
Breathalyser
6.2
7.6
19
31
S50.1
ICD-10 Finland
Contusion of other and unspecified parts of forearm
4.2
7.6
20
49
Y96.0
ICD-10 Finland
Work-related condition
4.2
7.6
20
49
N30.9
ICD-10 Finland
Cystitis, unspecified
2.3
7.6
57
258
N05BA12
ATC
alprazolam; oral
2.0
7.5
80
415
Z2221
NOMESCO Finland
Medical doctor
1.6
7.5
218
1517
SPAT1240
SPAT
Therapeutic discussion
1.8
7.5
119
706
L28
ICPC
Limited function/disability (L)
1.9
7.4
106
607
N05BA06
ATC
lorazepam; systemic, sublingual
2.6
7.4
42
166
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
6.5
7.4
18
28
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
3.4
7.4
26
78
R02
ICPC
Shortness of breath/dyspnoea
1.9
7.4
100
563
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.6
7.4
247
1773
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.4
7.3
49
210
S61.0
ICD-10 Finland
Open wound of finger(s) without damage to nail
1.9
7.3
95
528
R52.9
ICD-10 Finland
Pain, unspecified
1.9
7.3
89
484
S06.9
ICD-10 Finland
Intracranial injury, unspecified
11.0
7.3
13
12
X91.2
ICD-10 Finland
Assault by hanging, strangulation and suffocation by friend
+∞
7.3
7
*
F19.09
ICD-10 Finland
Intoxication caused by several drugs in combination and by other psychoactive substances UNS
+∞
7.3
7
*
A02BC05
ATC
esomeprazole; systemic
1.5
7.3
281
2080
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
2.8
7.3
36
133
N76.0
ICD-10 Finland
Acute vaginitis
2.0
7.2
82
435
M02AA07
ATC
piroxicam; topical
1.6
7.2
217
1519
V48.9
ICD-10 Finland
Car occupant injured in noncollision transport accident, unspecified car occupant injured in traffic accident
7.4
7.2
16
22
Z53.2
ICD-10 Finland
Procedure not carried out because of patient's decision for other and unspecified reasons
3.6
7.2
23
65
T78.4
ICD-10 Finland
Allergy, unspecified
2.4
7.2
48
206
SGC10
NOMESCO Finland
Pulp capping
1.9
7.1
101
577
S13.6
ICD-10 Finland
Sprain and strain of joints and ligaments of other and unspecified parts of neck
20.2
7.1
10
5
N05AF03
ATC
chlorprothixene; systemic
3.1
7.1
29
96
Z91.5
ICD-10 Finland
Personal history of self-harm
12.1
7.1
12
10
P06
ICPC
Sleep disturbance
1.7
7.1
125
764
ZXE10
NOMESCO Finland
More than one and less than three hours
1.5
7.1
238
1709
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
3.7
7.1
22
61
K59.09
ICD-10 Finland
Constipation, unspecified
2.4
7.1
49
214
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.8
7.0
112
664
S06.2
ICD-10 Finland
Diffuse brain injury
7.1
7.0
16
23
M01AH05
ATC
etoricoxib; oral
1.5
7.0
487
4047
F19.29
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances UNS
6.4
7.0
17
27
ZY010
NOMESCO Finland
Hospital outpatient
2.1
6.9
63
308
NB3AA
NOMESCO Finland
Clavicle X-ray examination
4.0
6.9
19
48
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
2.0
6.9
71
364
ZXA05
NOMESCO Finland
Left side
1.7
6.9
145
930
Y94.8
ICD-10 Finland
Other leisure activity accident
3.1
6.8
28
93
K04.08
ICD-10 Finland
Other specified pulpit
1.9
6.8
92
518
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.5
6.8
268
1987
T00.9
ICD-10 Finland
Multiple superficial injuries, unspecified
11.0
6.8
12
11
F13.29
ICD-10 Finland
Addiction caused by sedative and hypnotic UNS
9.4
6.8
13
14
S90.3
ICD-10 Finland
Contusion of other and unspecified parts of foot
2.5
6.8
40
162
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.8
6.8
99
572
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.9
6.8
83
453
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.0
6.7
69
353
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.1
6.7
66
333
WX110
NOMESCO Finland
Infiltration anesthesia
1.5
6.7
621
5439
K04.7
ICD-10 Finland
Periapical abscess without sinus
2.3
6.7
52
239
S63.4
ICD-10 Finland
Traumatic rupture of ligament of finger at metacarpophalangeal and interphalangeal joint(s)
3.2
6.6
25
79
XA402
NOMESCO Finland
ENMG
3.5
6.6
22
64
R25.2
ICD-10 Finland
Cramp and spasm
3.3
6.6
24
74
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.9
6.6
80
435
Z01.7
ICD-10 Finland
Laboratory examination
1.7
6.6
143
924
Z09.8
ICD-10 Finland
Follow-up examination after other treatment for other conditions
2.8
6.6
33
123
F13.1
ICD-10 Finland
Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use
8.8
6.6
13
15
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
3.9
6.6
19
50
A99
ICPC
Disease/condition unspecnature/site
1.9
6.6
84
465
SPAT1254
SPAT
Administration of medicine
1.7
6.6
115
701
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
1.8
6.5
96
555
N06AX03
ATC
mianserin; oral
2.6
6.5
37
147
N06AB03
ATC
fluoxetine; oral
1.8
6.5
101
594
EBA00
NOMESCO Finland
Extraction of tooth
1.5
6.4
324
2517
R03AC13
ATC
formoterol; inhalant
2.5
6.4
38
154
W20
ICD-10 Finland
Struck by thrown, projected or falling object(s)
4.1
6.4
17
42
F51.0
ICD-10 Finland
Nonorganic insomnia
1.6
6.4
173
1180
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
2.6
6.4
35
137
Z72.8
ICD-10 Finland
Other problems related to lifestyle
6.6
6.4
15
23
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
2.4
6.3
43
186
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.2
6.3
51
238
M79.7
ICD-10 Finland
Fibromyalgia
2.7
6.3
32
120
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.8
6.3
88
501
F43.00
ICD-10 Finland
Acute stress reaction mild
2.7
6.3
33
126
R69
ICD-10 Finland
Unknown and unspecified causes of morbidity
3.9
6.3
18
47
M53.0
ICD-10 Finland
Cervicocranial syndrome
1.8
6.3
87
494
NA2AD
NOMESCO Finland
Thoracic spine CT examination
18.2
6.3
9
5
Z50.1
ICD-10 Finland
Other physical therapy
2.5
6.3
38
156
S11.8
ICD-10 Finland
Open wound of other parts of neck
+∞
6.3
6
*
P74
ICPC
Anxiety disorder/anxiety state
2.0
6.3
68
356
H02AB07
ATC
prednisone; oral
1.8
6.2
89
510
G40.9
ICD-10 Finland
Epilepsy, unspecified
2.7
6.2
32
121
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.8
6.2
91
526
SFC01
NOMESCO Finland
Additional procedure necessary for restorative treatment
1.5
6.2
210
1505
R06.4
ICD-10 Finland
Hyperventilation
3.6
6.2
20
57
SPAT1211
SPAT
Application of soft bandage
2.0
6.2
70
372
SAA01
NOMESCO Finland
Simple examination of mouth
1.5
6.2
633
5602
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
2.2
6.2
50
234
S60.0
ICD-10 Finland
Contusion of finger(s) without damage to nail
2.3
6.1
43
189
J01FA06
ATC
roxithromycin; oral
1.5
6.1
276
2098
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
6.0
447
3715
L03
ICPC
Low back symptom/complaint
1.5
6.0
240
1776
K08.80
ICD-10 Finland
Toothache NOS
1.8
6.0
86
493
S43.4
ICD-10 Finland
Sprain and strain of shoulder joint
2.3
6.0
44
197
IGY99
NOMESCO Finland
Other psychiatric treatment contact
2.6
6.0
34
135
TimeCodeWAS
↥TODO / Current known limitations:
- Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
- Legend / how to read the glyphs.
- Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
- Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
- Download CSV.
- No filters and sorters.
- Limited amount of endpoints (~400) having TimeCodeWAS data.
- Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Emotionally unstable personality disorder, borderline condition
F60.31 [2000502023]
F60.31 [2000502023]
2.4e+00
2.9e+00
—
—
—
3.0e+00
2.9e+00
cases:1.99%
controls:0.18%
cases:1.52%
controls:0.08%
—
—
—
—
—
—
cases:1.21%
controls:0.06%
cases:2.34%
controls:0.14%
17
15
839
8535
13
7
843
8543
—
—
—
10
5
814
8304
17
10
710
7256
Fall on same level from slipping, tripping and stumbling
W01 [45756243]
W01 [45756243]
9.0e-01
1.1e+00
2.3e+00
1.0e+50
3.3e+00
1.3e+00
1.1e+00
cases:6.89%
controls:2.92%
cases:2.69%
controls:0.88%
cases:1.17%
controls:0.12%
cases:8.06%
controls:0.00%
cases:2.71%
controls:0.11%
cases:3.52%
controls:1.02%
cases:9.90%
controls:3.70%
59
250
797
8300
23
75
833
8475
10
10
846
8540
69
0
787
8550
23
9
827
8525
29
85
795
8224
72
269
655
6997
Psychiatry
26 [38004469]
26 [38004469]
9.4e-01
1.2e+00
1.1e+00
2.5e+00
1.6e+00
1.3e+00
1.3e+00
cases:15.89%
controls:6.87%
cases:10.75%
controls:3.56%
cases:4.56%
controls:1.53%
cases:1.75%
controls:0.14%
cases:6.94%
controls:1.48%
cases:11.77%
controls:3.62%
cases:20.36%
controls:6.73%
136
587
720
7963
92
304
764
8246
39
131
817
8419
15
12
841
8538
59
126
791
8408
97
301
727
8008
148
489
579
6777
Poisoning by systemic antibiotics
T36 [45756588]
T36 [45756588]
1.7e+00
2.4e+00
—
—
—
2.7e+00
2.7e+00
cases:2.80%
controls:0.54%
cases:1.29%
controls:0.12%
—
—
—
—
—
—
cases:1.70%
controls:0.12%
cases:3.99%
controls:0.29%
24
46
832
8504
11
10
845
8540
—
—
—
14
10
810
8299
29
21
698
7245
clonazepam; oral, parenteral
N03AE01 [21604415]
N03AE01 [21604415]
1.7e+00
1.7e+00
2.4e+00
—
—
1.9e+00
1.3e+00
cases:3.50%
controls:0.64%
cases:1.99%
controls:0.35%
cases:1.05%
controls:0.09%
—
—
—
—
cases:2.06%
controls:0.31%
cases:2.75%
controls:0.73%
30
55
826
8495
17
30
839
8520
9
8
847
8542
—
—
17
26
807
8283
20
53
707
7213
disulfiram; oral
N07BB01 [21604821]
N07BB01 [21604821]
1.7e+00
2.6e+00
—
—
—
2.8e+00
2.1e+00
cases:2.45%
controls:0.48%
cases:1.64%
controls:0.13%
—
—
—
—
—
—
cases:1.70%
controls:0.11%
cases:3.30%
controls:0.43%
21
41
835
8509
14
11
842
8539
—
—
—
14
9
810
8300
24
31
703
7235
Neurology
13 [38004458]
13 [38004458]
7.2e-01
7.1e-01
1.3e+00
2.8e+00
1.5e+00
1.0e+00
7.8e-01
cases:13.67%
controls:7.17%
cases:6.66%
controls:3.39%
cases:2.10%
controls:0.60%
cases:0.93%
controls:0.06%
cases:2.47%
controls:0.55%
cases:8.98%
controls:3.37%
cases:15.68%
controls:7.84%
117
613
739
7937
57
290
799
8260
18
51
838
8499
8
5
848
8545
21
47
829
8487
74
280
750
8029
114
570
613
6696
Mental and behavioural disorders due to use of alcohol, Harmful use
F10.1 [45595844]
F10.1 [45595844]
1.8e+00
2.1e+00
—
1.0e+50
—
2.5e+00
2.1e+00
cases:3.74%
controls:0.65%
cases:1.87%
controls:0.23%
—
—
cases:1.05%
controls:0.00%
—
—
cases:3.03%
controls:0.25%
cases:5.64%
controls:0.72%
32
56
824
8494
16
20
840
8530
—
9
0
847
8550
—
25
21
799
8288
41
52
686
7214
Emotionally unstable personality disorder, impulsive
F60.30 [2000502022]
F60.30 [2000502022]
1.9e+00
2.2e+00
1.7e+00
—
1.9e+00
1.9e+00
2.3e+00
cases:2.22%
controls:0.35%
cases:1.64%
controls:0.18%
cases:0.70%
controls:0.13%
—
—
cases:0.71%
controls:0.11%
cases:1.21%
controls:0.18%
cases:2.61%
controls:0.26%
19
30
837
8520
14
15
842
8535
6
11
850
8539
—
6
9
844
8525
10
15
814
8294
19
19
708
7247
Post-traumatic stress disorder
F43.1 [45595909]
F43.1 [45595909]
1.2e+00
2.0e+00
2.6e+00
—
—
2.3e+00
1.3e+00
cases:0.93%
controls:0.29%
cases:1.05%
controls:0.14%
cases:0.82%
controls:0.06%
—
—
—
—
cases:1.21%
controls:0.12%
cases:1.51%
controls:0.41%
8
25
848
8525
9
12
847
8538
7
5
849
8545
—
—
10
10
814
8299
11
30
716
7236
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
1988-5 [3020460]
3.0e-01
4.9e-01
1.1e+00
4.5e+00
9.8e-01
4.2e-01
4.4e-01
cases:30.49%
controls:24.50%
cases:21.26%
controls:14.23%
cases:7.24%
controls:2.42%
cases:8.76%
controls:0.11%
cases:6.71%
controls:2.64%
cases:21.24%
controls:15.04%
cases:43.05%
controls:32.84%
261
2095
595
6455
182
1217
674
7333
62
207
794
8343
75
9
781
8541
57
225
793
8309
175
1250
649
7059
313
2386
414
4880
General Practice
1 [38004446]
1 [38004446]
9.0e-01
1.1e+00
1.9e+00
—
2.5e+00
9.3e-01
8.4e-01
cases:22.43%
controls:10.54%
cases:10.51%
controls:3.93%
cases:2.45%
controls:0.36%
—
—
cases:3.88%
controls:0.33%
cases:8.98%
controls:3.75%
cases:21.73%
controls:10.69%
192
901
664
7649
90
336
766
8214
21
31
835
8519
—
33
28
817
8506
74
312
750
7997
158
777
569
6489
Emergency Room Visit
ER [9203]
ER [9203]
8.6e-01
1.0e+00
2.1e+00
—
2.0e+00
1.1e+00
1.0e+00
cases:51.17%
controls:30.74%
cases:24.18%
controls:10.35%
cases:7.94%
controls:1.02%
—
—
cases:8.94%
controls:1.25%
cases:24.39%
controls:9.80%
cases:49.93%
controls:26.52%
438
2628
418
5922
207
885
649
7665
68
87
788
8463
—
76
107
774
8427
201
814
623
7495
363
1927
364
5339
Addiction caused by alcohol UNS
F10.29 [2000501684]
F10.29 [2000501684]
2.8e+00
—
—
—
1.0e+50
2.6e+00
2.6e+00
cases:1.52%
controls:0.09%
—
—
—
—
—
—
cases:0.59%
controls:0.00%
cases:0.97%
controls:0.07%
cases:2.06%
controls:0.15%
13
8
843
8542
—
—
—
5
0
845
8534
8
6
816
8303
15
11
712
7255
paracetamol; oral, parenteral, rectal
N02BE01 [21604344]
N02BE01 [21604344]
5.1e-01
5.2e-01
6.2e-01
3.5e+00
1.6e+00
5.6e-01
6.3e-01
cases:36.80%
controls:25.86%
cases:20.33%
controls:13.19%
cases:4.21%
controls:2.30%
cases:1.99%
controls:0.06%
cases:8.35%
controls:1.85%
cases:21.24%
controls:13.37%
cases:45.94%
controls:31.16%
315
2211
541
6339
174
1128
682
7422
36
197
820
8353
17
5
839
8545
71
158
779
8376
175
1111
649
7198
334
2264
393
5002
Sprain and strain of cervical spine
S13.4 [45573197]
S13.4 [45573197]
2.5e+00
—
1.0e+50
1.0e+50
—
2.6e+00
2.9e+00
cases:1.29%
controls:0.11%
—
—
cases:0.58%
controls:0.00%
cases:1.29%
controls:0.00%
—
—
cases:1.09%
controls:0.08%
cases:3.03%
controls:0.18%
11
9
845
8541
—
5
0
851
8550
11
0
845
8550
—
9
7
815
8302
22
13
705
7253
Physical abuse
T74.1 [45594864]
T74.1 [45594864]
3.2e+00
—
1.0e+50
1.0e+50
—
2.3e+00
2.4e+00
cases:1.64%
controls:0.07%
—
—
cases:0.58%
controls:0.00%
cases:2.57%
controls:0.00%
—
—
cases:0.73%
controls:0.07%
cases:3.03%
controls:0.28%
14
6
842
8544
—
5
0
851
8550
22
0
834
8550
—
6
6
818
8303
22
20
705
7246
Exposure to unspecified factor
X59 [45756412]
X59 [45756412]
1.1e+00
1.4e+00
—
1.0e+50
2.8e+00
1.2e+00
1.2e+00
cases:6.19%
controls:2.06%
cases:2.80%
controls:0.71%
—
—
cases:4.67%
controls:0.00%
cases:1.76%
controls:0.11%
cases:2.55%
controls:0.78%
cases:6.74%
controls:2.17%
53
176
803
8374
24
61
832
8489
—
40
0
816
8550
15
9
835
8525
21
65
803
8244
49
158
678
7108
oxazepam; oral
N05BA04 [21604569]
N05BA04 [21604569]
9.6e-01
8.2e-01
1.4e+00
—
2.0e+00
1.3e+00
1.0e+00
cases:10.16%
controls:4.15%
cases:5.14%
controls:2.33%
cases:2.57%
controls:0.64%
—
—
cases:3.29%
controls:0.45%
cases:7.04%
controls:2.01%
cases:11.14%
controls:4.34%
87
355
769
8195
44
199
812
8351
22
55
834
8495
—
28
38
822
8496
58
167
766
8142
81
315
646
6951
Depressive episode, unspecified
F32.9 [45571760]
F32.9 [45571760]
1.4e+00
1.2e+00
1.3e+00
—
2.1e+00
1.6e+00
1.2e+00
cases:7.01%
controls:1.79%
cases:2.22%
controls:0.69%
cases:0.58%
controls:0.15%
—
—
cases:1.06%
controls:0.13%
cases:3.64%
controls:0.76%
cases:6.88%
controls:2.23%
60
153
796
8397
19
59
837
8491
5
13
851
8537
—
9
11
841
8523
30
63
794
8246
50
162
677
7104
Emergency Medicine
93 [38004510]
93 [38004510]
6.3e-01
9.4e-01
2.0e+00
—
1.8e+00
1.1e+00
7.6e-01
cases:20.09%
controls:11.80%
cases:13.43%
controls:5.71%
cases:4.67%
controls:0.65%
—
—
cases:4.00%
controls:0.67%
cases:15.53%
controls:5.92%
cases:30.12%
controls:16.82%
172
1009
684
7541
115
488
741
8062
40
56
816
8494
—
34
57
816
8477
128
492
696
7817
219
1222
508
6044
quetiapine; oral
N05AH04 [21604544]
N05AH04 [21604544]
1.1e+00
9.5e-01
1.3e+00
—
1.6e+00
1.1e+00
1.2e+00
cases:9.58%
controls:3.37%
cases:5.37%
controls:2.15%
cases:2.45%
controls:0.71%
—
—
cases:2.59%
controls:0.54%
cases:6.55%
controls:2.27%
cases:11.00%
controls:3.58%
82
288
774
8262
46
184
810
8366
21
61
835
8489
—
22
46
828
8488
54
189
770
8120
80
260
647
7006
Chronic viral hepatitis C
B18.2 [45590846]
B18.2 [45590846]
2.3e+00
2.6e+00
—
—
—
—
2.2e+00
cases:1.17%
controls:0.12%
cases:0.82%
controls:0.06%
—
—
—
—
—
—
—
—
cases:1.93%
controls:0.21%
10
10
846
8540
7
5
849
8545
—
—
—
—
14
15
713
7251
Cervical spine CT examination
NA1AD [2001306982]
NA1AD [2001306982]
2.0e+00
1.8e+00
—
1.0e+50
—
3.3e+00
1.8e+00
cases:1.52%
controls:0.20%
cases:0.70%
controls:0.12%
—
—
cases:10.86%
controls:0.00%
—
—
cases:1.58%
controls:0.06%
cases:2.48%
controls:0.43%
13
17
843
8533
6
10
850
8540
—
93
0
763
8550
—
13
5
811
8304
18
31
709
7235
diazepam; oral, parenteral, rectal
N05BA01 [21604566]
N05BA01 [21604566]
1.3e+00
1.4e+00
1.9e+00
—
1.4e+00
1.3e+00
1.1e+00
cases:6.89%
controls:2.05%
cases:4.09%
controls:0.99%
cases:1.05%
controls:0.15%
—
—
cases:1.18%
controls:0.30%
cases:3.52%
controls:0.94%
cases:5.09%
controls:1.83%
59
175
797
8375
35
85
821
8465
9
13
847
8537
—
10
26
840
8508
29
78
795
8231
37
133
690
7133
orphenadrine (citrate); oral, parenteral
M03BC01 [21604112]
M03BC01 [21604112]
7.5e-01
8.9e-01
1.5e+00
1.0e+50
2.3e+00
8.9e-01
6.6e-01
cases:11.45%
controls:5.75%
cases:4.44%
controls:1.87%
cases:1.17%
controls:0.26%
cases:0.58%
controls:0.00%
cases:1.53%
controls:0.15%
cases:4.49%
controls:1.89%
cases:11.69%
controls:6.41%
98
492
758
8058
38
160
818
8390
10
22
846
8528
5
0
851
8550
13
13
837
8521
37
157
787
8152
85
466
642
6800
orphenadrine (chloride); oral, parenteral
N04AB02 [21604458]
N04AB02 [21604458]
7.5e-01
8.9e-01
1.5e+00
1.0e+50
2.3e+00
8.9e-01
6.6e-01
cases:11.45%
controls:5.75%
cases:4.44%
controls:1.87%
cases:1.17%
controls:0.26%
cases:0.58%
controls:0.00%
cases:1.53%
controls:0.15%
cases:4.49%
controls:1.89%
cases:11.69%
controls:6.41%
98
492
758
8058
38
160
818
8390
10
22
846
8528
5
0
851
8550
13
13
837
8521
37
157
787
8152
85
466
642
6800
pregabalin; oral
N02BF02 [955152]
N02BF02 [955152]
1.0e+00
9.1e-01
1.3e+00
—
1.3e+00
1.3e+00
1.2e+00
cases:6.66%
controls:2.55%
cases:3.04%
controls:1.24%
cases:1.40%
controls:0.40%
—
—
cases:1.29%
controls:0.34%
cases:4.00%
controls:1.10%
cases:7.43%
controls:2.45%
57
218
799
8332
26
106
830
8444
12
34
844
8516
—
11
29
839
8505
33
91
791
8218
54
178
673
7088
codeine and paracetamol
N02AJ06 [1123647]
N02AJ06 [1123647]
6.3e-01
5.8e-01
6.2e-01
2.7e+00
1.7e+00
8.3e-01
6.2e-01
cases:18.69%
controls:10.90%
cases:7.24%
controls:4.20%
cases:1.17%
controls:0.63%
cases:1.17%
controls:0.08%
cases:3.53%
controls:0.69%
cases:9.10%
controls:4.19%
cases:20.08%
controls:11.86%
160
932
696
7618
62
359
794
8191
10
54
846
8496
10
7
846
8543
30
59
820
8475
75
348
749
7961
146
862
581
6404
General Surgery
2 [38004447]
2 [38004447]
7.0e-01
7.8e-01
1.7e+00
—
2.0e+00
9.8e-01
8.2e-01
cases:23.48%
controls:13.22%
cases:8.64%
controls:4.16%
cases:3.04%
controls:0.57%
—
—
cases:4.24%
controls:0.61%
cases:9.22%
controls:3.68%
cases:22.83%
controls:11.55%
201
1130
655
7420
74
356
782
8194
26
49
830
8501
—
36
52
814
8482
76
306
748
8003
166
839
561
6427
Anxiety disorder, unspecified
F41.9 [45542849]
F41.9 [45542849]
8.7e-01
1.3e+00
—
—
2.5e+00
1.5e+00
7.9e-01
cases:3.50%
controls:1.50%
cases:2.57%
controls:0.75%
—
—
—
—
cases:0.82%
controls:0.07%
cases:3.28%
controls:0.72%
cases:5.50%
controls:2.57%
30
128
826
8422
22
64
834
8486
—
—
7
6
843
8528
27
60
797
8249
40
187
687
7079
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
62238-1 [40764999]
2.0e-01
2.3e-01
9.3e-01
4.3e+00
9.4e-01
3.9e-01
3.6e-01
cases:21.03%
controls:17.95%
cases:16.47%
controls:13.51%
cases:5.72%
controls:2.34%
cases:7.94%
controls:0.12%
cases:6.24%
controls:2.54%
cases:18.93%
controls:13.70%
cases:35.49%
controls:27.69%
180
1535
676
7015
141
1155
715
7395
49
200
807
8350
68
10
788
8540
53
217
797
8317
156
1138
668
7171
258
2012
469
5254
Otolaryngology
4 [38004449]
4 [38004449]
4.8e-01
1.7e-01
1.4e+00
—
3.3e+00
1.1e+00
6.7e-01
cases:14.60%
controls:9.53%
cases:4.09%
controls:3.49%
cases:1.40%
controls:0.36%
—
—
cases:10.24%
controls:0.43%
cases:8.37%
controls:2.97%
cases:15.82%
controls:8.81%
125
815
731
7735
35
298
821
8252
12
31
844
8519
—
87
37
763
8497
69
247
755
8062
115
640
612
6626
Concussion
S06.0 [45582805]
S06.0 [45582805]
1.4e+00
1.9e+00
—
1.0e+50
—
1.9e+00
1.6e+00
cases:4.21%
controls:1.04%
cases:1.87%
controls:0.29%
—
—
cases:3.15%
controls:0.00%
—
—
cases:2.06%
controls:0.31%
cases:5.91%
controls:1.24%
36
89
820
8461
16
25
840
8525
—
27
0
829
8550
—
17
26
807
8283
43
90
684
7176
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
2951-2 [3019550]
2.5e-01
2.8e-01
9.3e-01
4.1e+00
9.1e-01
3.7e-01
3.7e-01
cases:28.27%
controls:23.53%
cases:20.33%
controls:16.18%
cases:6.31%
controls:2.60%
cases:9.58%
controls:0.18%
cases:6.59%
controls:2.77%
cases:21.84%
controls:16.19%
cases:41.54%
controls:32.82%
242
2012
614
6538
174
1383
682
7167
54
222
802
8328
82
15
774
8535
56
236
794
8298
180
1345
644
6964
302
2385
425
4881
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
2823-3 [3023103]
2.3e-01
2.7e-01
8.8e-01
4.1e+00
9.2e-01
4.0e-01
3.6e-01
cases:28.15%
controls:23.70%
cases:20.44%
controls:16.41%
cases:6.07%
controls:2.61%
cases:9.58%
controls:0.18%
cases:6.71%
controls:2.79%
cases:22.45%
controls:16.25%
cases:41.54%
controls:33.06%
241
2026
615
6524
175
1403
681
7147
52
223
804
8327
82
15
774
8535
57
238
793
8296
185
1350
639
6959
302
2402
425
4864
Chronic alcohol abuse
P15 [2002000811]
P15 [2002000811]
1.9e+00
1.7e+00
—
—
—
2.8e+00
1.8e+00
cases:1.40%
controls:0.22%
cases:0.70%
controls:0.13%
—
—
—
—
—
—
cases:0.97%
controls:0.06%
cases:2.06%
controls:0.36%
12
19
844
8531
6
11
850
8539
—
—
—
8
5
816
8304
15
26
712
7240
Emergency Room and Inpatient Visit
ERIP [262]
ERIP [262]
6.8e-01
6.8e-01
2.2e+00
—
1.5e+00
6.6e-01
6.6e-01
cases:6.54%
controls:3.44%
cases:3.86%
controls:1.99%
cases:1.40%
controls:0.16%
—
—
cases:1.29%
controls:0.29%
cases:3.88%
controls:2.05%
cases:11.28%
controls:6.19%
56
294
800
8256
33
170
823
8380
12
14
844
8536
—
11
25
839
8509
32
170
792
8139
82
450
645
6816
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
X69 [45585661]
X69 [45585661]
1.6e+00
2.5e+00
—
—
—
—
2.2e+00
cases:1.99%
controls:0.40%
cases:0.82%
controls:0.07%
—
—
—
—
—
—
—
—
cases:2.20%
controls:0.25%
17
34
839
8516
7
6
849
8544
—
—
—
—
16
18
711
7248
Car occupant [any] injured in unspecified traffic accident
V49.9 [45566025]
V49.9 [45566025]
1.5e+00
—
—
1.0e+50
—
2.8e+00
2.0e+00
cases:1.40%
controls:0.32%
—
—
—
—
cases:8.41%
controls:0.00%
—
—
cases:0.97%
controls:0.06%
cases:1.65%
controls:0.23%
12
27
844
8523
—
—
72
0
784
8550
—
8
5
816
8304
12
17
715
7249
Methadone [Presence] in Urine by Screen method
19550-3 [3028707]
19550-3 [3028707]
1.3e+00
1.8e+00
—
—
—
1.6e+00
1.6e+00
cases:2.10%
controls:0.61%
cases:1.29%
controls:0.22%
—
—
—
—
—
—
cases:1.21%
controls:0.24%
cases:4.13%
controls:0.85%
18
52
838
8498
11
19
845
8531
—
—
—
10
20
814
8289
30
62
697
7204
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
14682-9 [3020564]
2.1e-01
2.5e-01
8.4e-01
4.0e+00
7.8e-01
3.4e-01
2.8e-01
cases:31.31%
controls:26.89%
cases:23.83%
controls:19.59%
cases:7.83%
controls:3.54%
cases:10.40%
controls:0.21%
cases:7.76%
controls:3.71%
cases:25.85%
controls:19.92%
cases:45.12%
controls:38.29%
268
2299
588
6251
204
1675
652
6875
67
303
789
8247
89
18
767
8532
66
317
784
8217
213
1655
611
6654
328
2782
399
4484
Orthopedic Surgery
20 [38004465]
20 [38004465]
7.2e-01
8.5e-01
1.3e+00
—
1.6e+00
8.6e-01
8.6e-01
cases:18.22%
controls:9.78%
cases:8.64%
controls:3.87%
cases:1.52%
controls:0.43%
—
—
cases:3.53%
controls:0.74%
cases:8.50%
controls:3.78%
cases:23.93%
controls:11.74%
156
836
700
7714
74
331
782
8219
13
37
843
8513
—
30
63
820
8471
70
314
754
7995
174
853
553
6413
temazepam; oral
N05CD07 [21604642]
N05CD07 [21604642]
9.1e-01
1.2e+00
1.4e+00
—
1.1e+00
1.2e+00
1.4e+00
cases:5.72%
controls:2.39%
cases:4.44%
controls:1.35%
cases:1.40%
controls:0.36%
—
—
cases:1.06%
controls:0.36%
cases:4.00%
controls:1.30%
cases:7.98%
controls:2.15%
49
204
807
8346
38
115
818
8435
12
31
844
8519
—
9
31
841
8503
33
108
791
8201
58
156
669
7110
Cervicalgia
M54.2 [45591867]
M54.2 [45591867]
5.7e-01
1.0e+00
—
1.0e+50
2.5e+00
2.3e+00
1.0e+00
cases:1.17%
controls:0.67%
cases:0.70%
controls:0.26%
—
—
cases:1.17%
controls:0.00%
cases:0.71%
controls:0.06%
cases:1.21%
controls:0.12%
cases:2.20%
controls:0.80%
10
57
846
8493
6
22
850
8528
—
10
0
846
8550
6
5
844
8529
10
10
814
8299
16
58
711
7208
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]
1798-8 [3016771]
4.7e-01
9.6e-01
1.6e+00
—
1.5e+00
1.0e+00
7.7e-01
cases:7.13%
controls:4.57%
cases:4.09%
controls:1.60%
cases:1.05%
controls:0.22%
—
—
cases:1.06%
controls:0.25%
cases:4.61%
controls:1.67%
cases:11.42%
controls:5.66%
61
391
795
8159
35
137
821
8413
9
19
847
8531
—
9
21
841
8513
38
139
786
8170
83
411
644
6855
Open wound of scalp
S01.0 [45592468]
S01.0 [45592468]
1.0e+00
2.1e+00
—
1.0e+50
—
2.2e+00
1.3e+00
cases:1.52%
controls:0.54%
cases:1.17%
controls:0.14%
—
—
cases:1.05%
controls:0.00%
—
—
cases:0.97%
controls:0.11%
cases:2.34%
controls:0.65%
13
46
843
8504
10
12
846
8538
—
9
0
847
8550
—
8
9
816
8300
17
47
710
7219
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
N02AX02 [21604298]
8.5e-01
8.8e-01
—
—
1.9e+00
9.3e-01
1.1e+00
cases:12.27%
controls:5.65%
cases:4.56%
controls:1.94%
—
—
—
—
cases:2.35%
controls:0.35%
cases:4.00%
controls:1.62%
cases:13.89%
controls:5.31%
105
483
751
8067
39
166
817
8384
—
—
20
30
830
8504
33
135
791
8174
101
386
626
6880
Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
21416-3 [3003510]
21416-3 [3003510]
5.5e-01
7.5e-01
8.7e-01
—
2.4e+00
9.1e-01
7.9e-01
cases:7.83%
controls:4.68%
cases:3.50%
controls:1.68%
cases:0.58%
controls:0.25%
—
—
cases:1.18%
controls:0.11%
cases:4.00%
controls:1.65%
cases:9.90%
controls:4.73%
67
400
789
8150
30
144
826
8406
5
21
851
8529
—
10
9
840
8525
33
137
791
8172
72
344
655
6922
CBC panel - Blood by Automated count
58410-2 [40761511]
58410-2 [40761511]
2.1e-01
1.1e-01
6.3e-01
3.7e+00
6.2e-01
2.9e-01
3.9e-01
cases:31.19%
controls:26.91%
cases:18.81%
controls:17.16%
cases:5.61%
controls:3.05%
cases:7.13%
controls:0.19%
cases:5.18%
controls:2.85%
cases:21.12%
controls:16.69%
cases:44.70%
controls:35.36%
267
2301
589
6249
161
1467
695
7083
48
261
808
8289
61
16
795
8534
44
243
806
8291
174
1387
650
6922
325
2569
402
4697
Buprenorphine [Presence] in Urine by Screen method
93494-3 [1001926]
93494-3 [1001926]
1.1e+00
1.3e+00
—
—
—
1.5e+00
1.4e+00
cases:2.80%
controls:0.97%
cases:1.40%
controls:0.39%
—
—
—
—
—
—
cases:1.82%
controls:0.40%
cases:5.23%
controls:1.35%
24
83
832
8467
12
33
844
8517
—
—
—
15
33
809
8276
38
98
689
7168
Platelets [#/volume] in Blood
26515-7 [3007461]
26515-7 [3007461]
1.9e-01
1.6e-01
7.2e-01
3.6e+00
5.8e-01
2.7e-01
2.3e-01
cases:35.98%
controls:31.82%
cases:27.80%
controls:24.70%
cases:10.16%
controls:5.22%
cases:10.05%
controls:0.32%
cases:9.06%
controls:5.30%
cases:30.70%
controls:25.33%
cases:50.76%
controls:45.00%
308
2721
548
5829
238
2112
618
6438
87
446
769
8104
86
27
770
8523
77
452
773
8082
253
2105
571
6204
369
3270
358
3996
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
30428-7 [3024731]
1.9e-01
1.6e-01
7.2e-01
3.6e+00
5.8e-01
2.6e-01
2.3e-01
cases:36.10%
controls:31.91%
cases:27.92%
controls:24.77%
cases:10.16%
controls:5.24%
cases:10.05%
controls:0.32%
cases:9.06%
controls:5.30%
cases:30.70%
controls:25.37%
cases:50.89%
controls:45.17%
309
2728
547
5822
239
2118
617
6432
87
448
769
8102
86
27
770
8523
77
452
773
8082
253
2108
571
6201
370
3282
357
3984
levomepromazine; oral, parenteral
N05AA02 [21604493]
N05AA02 [21604493]
1.6e+00
1.9e+00
—
—
-1.0e+50
—
1.6e+00
cases:1.75%
controls:0.36%
cases:1.29%
controls:0.19%
—
—
—
—
cases:0.00%
controls:0.08%
—
—
cases:1.38%
controls:0.29%
15
31
841
8519
11
16
845
8534
—
—
0
7
850
8527
—
10
21
717
7245
Drugs identified in Urine by Screen method Nominal
12286-1 [3011288]
12286-1 [3011288]
1.3e+00
1.3e+00
—
—
—
1.4e+00
1.1e+00
cases:2.80%
controls:0.80%
cases:1.52%
controls:0.43%
—
—
—
—
—
—
cases:1.58%
controls:0.40%
cases:3.99%
controls:1.32%
24
68
832
8482
13
37
843
8513
—
—
—
13
33
811
8276
29
96
698
7170
Inpatient Hospital
21 [8717]
21 [8717]
3.5e-01
4.2e-01
1.1e+00
—
1.7e+00
7.3e-01
7.0e-01
cases:36.92%
controls:29.17%
cases:12.85%
controls:8.81%
cases:3.04%
controls:1.01%
—
—
cases:6.00%
controls:1.10%
cases:14.56%
controls:7.62%
cases:34.80%
controls:21.02%
316
2494
540
6056
110
753
746
7797
26
86
830
8464
—
51
94
799
8440
120
633
704
7676
253
1527
474
5739
olanzapine; oral, parenteral
N05AH03 [21604543]
N05AH03 [21604543]
1.3e+00
1.2e+00
7.8e-01
—
—
1.3e+00
1.2e+00
cases:3.15%
controls:0.85%
cases:2.10%
controls:0.63%
cases:0.58%
controls:0.27%
—
—
—
—
cases:2.06%
controls:0.59%
cases:3.16%
controls:0.98%
27
73
829
8477
18
54
838
8496
5
23
851
8527
—
—
17
49
807
8260
23
71
704
7195
Alcohol dependence periodic alcoholism
F10.26 [2000501683]
F10.26 [2000501683]
2.5e+00
—
—
—
—
—
2.5e+00
cases:0.82%
controls:0.07%
—
—
—
—
—
—
—
—
—
—
cases:0.96%
controls:0.08%
7
6
849
8544
—
—
—
—
—
7
6
720
7260
valproic acid; oral, parenteral, rectal
N03AG01 [21604422]
N03AG01 [21604422]
1.2e+00
1.3e+00
1.3e+00
—
—
1.1e+00
1.4e+00
cases:3.15%
controls:1.02%
cases:2.69%
controls:0.78%
cases:0.93%
controls:0.27%
—
—
—
—
cases:2.55%
controls:0.84%
cases:3.99%
controls:1.03%
27
87
829
8463
23
67
833
8483
8
23
848
8527
—
—
21
70
803
8239
29
75
698
7191
Supplier / Service Provider
OMOP5117446 [33004]
OMOP5117446 [33004]
-7.1e-01
-7.2e-01
—
—
—
3.0e+00
3.3e+00
cases:15.42%
controls:27.04%
cases:4.32%
controls:8.51%
—
—
—
—
—
—
cases:4.37%
controls:0.22%
cases:13.76%
controls:0.61%
132
2312
724
6238
37
728
819
7822
—
—
—
36
18
788
8291
100
44
627
7222
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
20570-8 [3009542]
1.9e-01
1.6e-01
7.2e-01
3.6e+00
5.9e-01
2.6e-01
2.3e-01
cases:36.10%
controls:31.91%
cases:27.92%
controls:24.77%
cases:10.16%
controls:5.24%
cases:10.16%
controls:0.32%
cases:9.18%
controls:5.32%
cases:30.70%
controls:25.42%
cases:50.89%
controls:45.22%
309
2728
547
5822
239
2118
617
6432
87
448
769
8102
87
27
769
8523
78
454
772
8080
253
2112
571
6197
370
3286
357
3980
Choriogonadotropin [Units/volume] in Serum or Plasma
19080-1 [3018171]
19080-1 [3018171]
8.8e-01
1.4e+00
—
—
-1.0e+50
1.4e+00
1.3e+00
cases:3.74%
controls:1.59%
cases:2.22%
controls:0.57%
—
—
—
—
cases:0.00%
controls:0.08%
cases:1.82%
controls:0.47%
cases:6.19%
controls:1.84%
32
136
824
8414
19
49
837
8501
—
—
0
7
850
8527
15
39
809
8270
45
134
682
7132
MCH [Entitic mass]
28539-5 [3035941]
28539-5 [3035941]
1.9e-01
1.6e-01
7.2e-01
3.6e+00
5.7e-01
2.6e-01
2.3e-01
cases:36.10%
controls:31.89%
cases:27.92%
controls:24.74%
cases:10.16%
controls:5.24%
cases:10.05%
controls:0.32%
cases:9.06%
controls:5.31%
cases:30.70%
controls:25.41%
cases:50.89%
controls:45.21%
309
2727
547
5823
239
2115
617
6435
87
448
769
8102
86
27
770
8523
77
453
773
8081
253
2111
571
6198
370
3285
357
3981
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
26453-1 [3026361]
1.9e-01
1.6e-01
7.2e-01
3.6e+00
5.7e-01
2.6e-01
2.3e-01
cases:36.10%
controls:31.89%
cases:27.92%
controls:24.77%
cases:10.16%
controls:5.24%
cases:10.05%
controls:0.32%
cases:9.06%
controls:5.32%
cases:30.70%
controls:25.43%
cases:50.89%
controls:45.22%
309
2727
547
5823
239
2118
617
6432
87
448
769
8102
86
27
770
8523
77
454
773
8080
253
2113
571
6196
370
3286
357
3980
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
718-7 [3000963]
1.9e-01
1.6e-01
7.1e-01
3.6e+00
5.7e-01
2.6e-01
2.2e-01
cases:36.21%
controls:31.98%
cases:27.92%
controls:24.84%
cases:10.16%
controls:5.29%
cases:10.05%
controls:0.32%
cases:9.06%
controls:5.34%
cases:30.70%
controls:25.54%
cases:50.89%
controls:45.32%
310
2734
546
5816
239
2124
617
6426
87
452
769
8098
86
27
770
8523
77
456
773
8078
253
2122
571
6187
370
3293
357
3973
Leukocytes [#/volume] in Blood
26464-8 [3010813]
26464-8 [3010813]
1.8e-01
1.6e-01
7.1e-01
3.5e+00
5.7e-01
2.6e-01
2.3e-01
cases:36.10%
controls:31.98%
cases:27.92%
controls:24.82%
cases:10.16%
controls:5.26%
cases:9.93%
controls:0.32%
cases:9.06%
controls:5.32%
cases:30.70%
controls:25.48%
cases:51.03%
controls:45.24%
309
2734
547
5816
239
2122
617
6428
87
450
769
8100
85
27
771
8523
77
454
773
8080
253
2117
571
6192
371
3287
356
3979
Outpatient Visit
OP [9202]
OP [9202]
3.0e-01
2.4e-01
2.8e-01
2.4e+00
9.1e-01
4.6e-01
4.7e-01
cases:71.61%
controls:65.15%
cases:50.12%
controls:44.15%
cases:11.92%
controls:9.24%
cases:4.79%
controls:0.43%
cases:20.71%
controls:9.54%
cases:54.73%
controls:43.17%
cases:80.19%
controls:71.68%
613
5570
243
2980
429
3775
427
4775
102
790
754
7760
41
37
815
8513
176
814
674
7720
451
3587
373
4722
583
5208
144
2058
Sprain and strain of ankle
S93.4 [45550848]
S93.4 [45550848]
8.7e-01
1.6e+00
—
—
—
1.3e+00
1.1e+00
cases:3.39%
controls:1.45%
cases:1.75%
controls:0.37%
—
—
—
—
—
—
cases:1.33%
controls:0.36%
cases:3.99%
controls:1.42%
29
124
827
8426
15
32
841
8518
—
—
—
11
30
813
8279
29
103
698
7163
Cocaine [Presence] in Urine
3397-7 [3016879]
3397-7 [3016879]
1.0e+00
1.3e+00
—
—
2.3e+00
1.3e+00
1.2e+00
cases:3.27%
controls:1.19%
cases:1.64%
controls:0.47%
—
—
—
—
cases:0.59%
controls:0.06%
cases:1.70%
controls:0.47%
cases:5.50%
controls:1.71%
28
102
828
8448
14
40
842
8510
—
—
5
5
845
8529
14
39
810
8270
40
124
687
7142
Exposure to other specified factors
X58 [45756411]
X58 [45756411]
9.1e-01
1.2e+00
—
—
—
1.3e+00
1.3e+00
cases:3.74%
controls:1.53%
cases:1.75%
controls:0.51%
—
—
—
—
—
—
cases:1.58%
controls:0.42%
cases:6.74%
controls:1.91%
32
131
824
8419
15
44
841
8506
—
—
—
13
35
811
8274
49
139
678
7127
Pharmacy visit
OMOP4822462 [581458]
OMOP4822462 [581458]
6.4e-01
4.4e-01
3.0e-01
1.5e+00
7.0e-01
3.9e-01
7.8e-01
cases:95.68%
controls:92.08%
cases:83.41%
controls:76.47%
cases:42.17%
controls:35.03%
cases:7.59%
controls:1.73%
cases:51.76%
controls:34.80%
cases:83.62%
controls:77.52%
cases:96.70%
controls:93.09%
819
7873
37
677
714
6538
142
2012
361
2995
495
5555
65
148
791
8402
440
2970
410
5564
689
6441
135
1868
703
6764
24
502
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 [3007220]
2157-6 [3007220]
6.9e-01
8.1e-01
2.3e+00
1.0e+50
1.4e+00
7.1e-01
8.2e-01
cases:7.13%
controls:3.70%
cases:3.39%
controls:1.53%
cases:0.82%
controls:0.08%
cases:2.10%
controls:0.00%
cases:0.82%
controls:0.21%
cases:2.67%
controls:1.34%
cases:9.08%
controls:4.21%
61
316
795
8234
29
131
827
8419
7
7
849
8543
18
0
838
8550
7
18
843
8516
22
111
802
8198
66
306
661
6960
Laceration/cut
S18 [2002000983]
S18 [2002000983]
6.6e-01
7.5e-01
1.2e+00
—
1.7e+00
9.4e-01
5.7e-01
cases:9.46%
controls:5.13%
cases:4.56%
controls:2.20%
cases:0.82%
controls:0.26%
—
—
cases:1.06%
controls:0.20%
cases:4.25%
controls:1.71%
cases:10.18%
controls:6.03%
81
439
775
8111
39
188
817
8362
7
22
849
8528
—
9
17
841
8517
35
142
789
8167
74
438
653
6828
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
30385-9 [3002385]
2.0e-01
2.5e-01
6.7e-01
3.5e+00
4.5e-01
2.5e-01
3.1e-01
cases:23.95%
controls:20.51%
cases:18.93%
controls:15.40%
cases:6.43%
controls:3.39%
cases:7.83%
controls:0.25%
cases:5.41%
controls:3.53%
cases:19.30%
controls:15.67%
cases:36.59%
controls:29.74%
205
1754
651
6796
162
1317
694
7233
55
290
801
8260
67
21
789
8529
46
301
804
8233
159
1302
665
7007
266
2161
461
5105
Case Management Agency
251B00000X [38004193]
251B00000X [38004193]
1.1e-01
2.2e-01
4.3e-01
3.5e+00
5.7e-01
2.3e-01
1.1e-01
cases:59.93%
controls:57.22%
cases:56.66%
controls:51.11%
cases:29.09%
controls:21.08%
cases:32.83%
controls:1.44%
cases:31.65%
controls:20.81%
cases:59.10%
controls:53.52%
cases:70.43%
controls:68.13%
513
4892
343
3658
485
4370
371
4180
249
1802
607
6748
281
123
575
8427
269
1776
581
6758
487
4447
337
3862
512
4950
215
2316
Alcohol intoxication UNS
F10.09 [2000501676]
F10.09 [2000501676]
1.7e+00
2.2e+00
—
—
—
—
2.3e+00
cases:0.82%
controls:0.15%
cases:0.70%
controls:0.08%
—
—
—
—
—
—
—
—
cases:1.65%
controls:0.17%
7
13
849
8537
6
7
850
8543
—
—
—
—
12
12
715
7254
Laboratory Visit
OMOP4822461 [32036]
OMOP4822461 [32036]
1.3e-01
1.6e-01
5.9e-01
3.3e+00
5.6e-01
1.8e-01
9.8e-02
cases:40.42%
controls:37.27%
cases:37.50%
controls:33.87%
cases:16.47%
controls:9.81%
cases:11.92%
controls:0.50%
cases:15.41%
controls:9.41%
cases:39.44%
controls:35.18%
cases:54.33%
controls:51.90%
346
3187
510
5363
321
2896
535
5654
141
839
715
7711
102
43
754
8507
131
803
719
7731
325
2923
499
5386
395
3771
332
3495
fluoxetine; oral
N06AB03 [21604711]
N06AB03 [21604711]
8.0e-01
1.0e+00
1.4e+00
—
1.5e+00
1.5e+00
1.1e+00
cases:3.15%
controls:1.44%
cases:1.75%
controls:0.63%
cases:0.70%
controls:0.18%
—
—
cases:0.71%
controls:0.16%
cases:2.31%
controls:0.53%
cases:3.16%
controls:1.10%
27
123
829
8427
15
54
841
8496
6
15
850
8535
—
6
14
844
8520
19
44
805
8265
23
80
704
7186
Opiates [Presence] in Urine
3879-4 [3027008]
3879-4 [3027008]
9.7e-01
1.1e+00
—
—
2.1e+00
1.2e+00
1.1e+00
cases:3.27%
controls:1.26%
cases:1.64%
controls:0.55%
—
—
—
—
cases:0.59%
controls:0.07%
cases:1.70%
controls:0.53%
cases:5.50%
controls:1.89%
28
108
828
8442
14
47
842
8503
—
—
5
6
845
8528
14
44
810
8265
40
137
687
7129
Cannabinoids [Presence] in Urine
3427-2 [3028300]
3427-2 [3028300]
9.6e-01
1.1e+00
—
—
2.1e+00
1.2e+00
1.1e+00
cases:3.27%
controls:1.27%
cases:1.64%
controls:0.55%
—
—
—
—
cases:0.59%
controls:0.07%
cases:1.70%
controls:0.53%
cases:5.50%
controls:1.87%
28
109
828
8441
14
47
842
8503
—
—
5
6
845
8528
14
44
810
8265
40
136
687
7130
Benzodiazepines [Presence] in Urine
3390-2 [3000764]
3390-2 [3000764]
9.5e-01
1.1e+00
—
—
2.1e+00
1.2e+00
1.1e+00
cases:3.27%
controls:1.29%
cases:1.64%
controls:0.55%
—
—
—
—
cases:0.59%
controls:0.07%
cases:1.70%
controls:0.53%
cases:5.50%
controls:1.89%
28
110
828
8440
14
47
842
8503
—
—
5
6
845
8528
14
44
810
8265
40
137
687
7129
Recurrent depressive disorder, unspecified
F33.9 [45581458]
F33.9 [45581458]
1.1e+00
1.5e+00
—
—
—
1.8e+00
1.4e+00
cases:1.52%
controls:0.51%
cases:0.70%
controls:0.16%
—
—
—
—
—
—
cases:1.09%
controls:0.18%
cases:2.20%
controls:0.54%
13
44
843
8506
6
14
850
8536
—
—
—
9
15
815
8294
16
39
711
7227
Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
6357-8 [3024950]
6357-8 [3024950]
5.1e-01
6.6e-01
—
—
2.2e+00
9.1e-01
6.9e-01
cases:8.64%
controls:5.37%
cases:3.62%
controls:1.91%
—
—
—
—
cases:1.06%
controls:0.12%
cases:4.49%
controls:1.87%
cases:10.04%
controls:5.30%
74
459
782
8091
31
163
825
8387
—
—
9
10
841
8524
37
155
787
8154
73
385
654
6881
Urine methamphetamine measurement
313579004 [4198724]
313579004 [4198724]
2.0e+00
—
—
—
—
—
2.3e+00
cases:1.17%
controls:0.16%
—
—
—
—
—
—
—
—
—
—
cases:1.65%
controls:0.17%
10
14
846
8536
—
—
—
—
—
12
12
715
7254
hydroxyzine; oral, parenteral
N05BB01 [21604590]
N05BB01 [21604590]
1.1e+00
1.2e+00
—
—
—
1.0e+00
9.8e-01
cases:5.02%
controls:1.74%
cases:2.10%
controls:0.65%
—
—
—
—
—
—
cases:2.18%
controls:0.79%
cases:4.68%
controls:1.82%
43
149
813
8401
18
56
838
8494
—
—
—
18
66
806
8243
34
132
693
7134
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
28540-3 [3003338]
1.4e-01
1.4e-01
7.2e-01
3.5e+00
5.0e-01
1.5e-01
7.2e-02
cases:26.75%
controls:24.05%
cases:19.16%
controls:17.15%
cases:7.01%
controls:3.56%
cases:7.01%
controls:0.23%
cases:5.88%
controls:3.64%
cases:19.66%
controls:17.39%
cases:35.63%
controls:33.99%
229
2056
627
6494
164
1466
692
7084
60
304
796
8246
60
20
796
8530
50
311
800
8223
162
1445
662
6864
259
2470
468
4796
Office Visit
OMOP4822458 [581477]
OMOP4822458 [581477]
3.6e-01
6.5e-01
8.0e-01
—
2.1e+00
8.2e-01
5.7e-01
cases:12.03%
controls:8.73%
cases:4.56%
controls:2.43%
cases:0.70%
controls:0.32%
—
—
cases:3.06%
controls:0.39%
cases:5.22%
controls:2.36%
cases:10.59%
controls:6.30%
103
746
753
7804
39
208
817
8342
6
27
850
8523
—
26
33
824
8501
43
196
781
8113
77
458
650
6808
Normoblasts [#/volume] in Blood
715-3 [3021589]
715-3 [3021589]
9.0e-02
2.6e-01
5.1e-01
3.5e+00
2.9e-01
2.7e-01
5.4e-01
cases:8.41%
controls:7.74%
cases:7.36%
controls:5.79%
cases:1.99%
controls:1.20%
cases:1.99%
controls:0.06%
cases:1.76%
controls:1.32%
cases:7.52%
controls:5.87%
cases:16.92%
controls:10.64%
72
662
784
7888
63
495
793
8055
17
103
839
8447
17
5
839
8545
15
113
835
8421
62
488
762
7821
123
773
604
6493
Recurrent depression, moderate episode without somatic syndrome
F33.10 [2000501984]
F33.10 [2000501984]
1.1e+00
8.7e-01
—
—
1.9e+00
1.0e+00
1.1e+00
cases:1.99%
controls:0.69%
cases:1.17%
controls:0.49%
—
—
—
—
cases:0.82%
controls:0.13%
cases:1.33%
controls:0.49%
cases:2.89%
controls:0.95%
17
59
839
8491
10
42
846
8508
—
—
7
11
843
8523
11
41
813
8268
21
69
706
7197
Headache
R51.80 [2000503603]
R51.80 [2000503603]
9.0e-01
1.1e+00
2.1e+00
—
—
9.8e-01
1.1e+00
cases:5.14%
controls:2.16%
cases:1.99%
controls:0.68%
cases:0.58%
controls:0.07%
—
—
—
—
cases:1.94%
controls:0.73%
cases:6.60%
controls:2.31%
44
185
812
8365
17
58
839
8492
5
6
851
8544
—
—
16
61
808
8248
48
168
679
7098
Alcohol dependence currently independent
F10.20 [2000501677]
F10.20 [2000501677]
1.8e+00
—
—
—
—
—
2.2e+00
cases:1.05%
controls:0.18%
—
—
—
—
—
—
—
—
—
—
cases:1.38%
controls:0.15%
9
15
847
8535
—
—
—
—
—
10
11
717
7255
Contusion of lower back and pelvis
S30.0 [45549279]
S30.0 [45549279]
2.2e+00
—
—
1.0e+50
—
—
1.8e+00
cases:1.52%
controls:0.18%
—
—
—
—
cases:2.10%
controls:0.00%
—
—
—
—
cases:1.65%
controls:0.28%
13
15
843
8535
—
—
18
0
838
8550
—
—
12
20
715
7246
Epithelial cells.squamous [#/volume] in Urine by Automated count
51486-9 [3029879]
51486-9 [3029879]
6.9e-01
3.1e-01
—
1.0e+50
1.7e+00
9.1e-01
6.8e-01
cases:3.74%
controls:1.91%
cases:1.40%
controls:1.03%
—
—
cases:0.82%
controls:0.00%
cases:0.94%
controls:0.18%
cases:2.18%
controls:0.89%
cases:5.78%
controls:3.00%
32
163
824
8387
12
88
844
8462
—
7
0
849
8550
8
15
842
8519
18
74
806
8235
42
218
685
7048
Severe depressive episode without psychotic symptoms
F32.2 [45557202]
F32.2 [45557202]
6.9e-01
1.3e+00
—
—
—
1.4e+00
1.2e+00
cases:1.87%
controls:0.95%
cases:1.29%
controls:0.34%
—
—
—
—
—
—
cases:1.21%
controls:0.29%
cases:2.34%
controls:0.73%
16
81
840
8469
11
29
845
8521
—
—
—
10
24
814
8285
17
53
710
7213
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]
2324-2 [3026910]
2.8e-01
5.7e-01
1.1e+00
—
1.3e+00
6.4e-01
3.8e-01
cases:16.82%
controls:13.25%
cases:9.00%
controls:5.31%
cases:1.64%
controls:0.56%
—
—
cases:1.88%
controls:0.54%
cases:10.07%
controls:5.58%
cases:24.76%
controls:18.33%
144
1133
712
7417
77
454
779
8096
14
48
842
8502
—
16
46
834
8488
83
464
741
7845
180
1332
547
5934
Outpatient Hospital
22 [8756]
22 [8756]
3.4e-01
4.8e-01
8.7e-01
—
1.7e+00
6.6e-01
6.9e-01
cases:26.87%
controls:20.70%
cases:8.41%
controls:5.38%
cases:1.52%
controls:0.64%
—
—
cases:3.18%
controls:0.59%
cases:8.62%
controls:4.65%
cases:24.90%
controls:14.27%
230
1770
626
6780
72
460
784
8090
13
55
843
8495
—
27
50
823
8484
71
386
753
7923
181
1037
546
6229
Dorsalgia, unspecified
M54.9 [45538791]
M54.9 [45538791]
1.3e+00
1.5e+00
—
—
—
—
1.1e+00
cases:3.86%
controls:1.10%
cases:1.29%
controls:0.30%
—
—
—
—
—
—
—
—
cases:3.44%
controls:1.17%
33
94
823
8456
11
26
845
8524
—
—
—
—
25
85
702
7181
citalopram; oral, parenteral
N06AB04 [21604712]
N06AB04 [21604712]
8.7e-01
1.0e+00
1.2e+00
—
1.1e+00
9.2e-01
1.0e+00
cases:6.31%
controls:2.74%
cases:3.15%
controls:1.17%
cases:0.70%
controls:0.21%
—
—
cases:1.06%
controls:0.36%
cases:3.40%
controls:1.38%
cases:6.19%
controls:2.34%
54
234
802
8316
27
100
829
8450
6
18
850
8532
—
9
31
841
8503
28
115
796
8194
45
170
682
7096
gabapentin; oral
N02BF01 [955005]
N02BF01 [955005]
1.1e+00
8.4e-01
4.6e-01
—
1.2e+00
8.8e-01
9.3e-01
cases:5.02%
controls:1.65%
cases:2.80%
controls:1.23%
cases:0.70%
controls:0.44%
—
—
cases:1.29%
controls:0.40%
cases:3.52%
controls:1.49%
cases:6.88%
controls:2.84%
43
141
813
8409
24
105
832
8445
6
38
850
8512
—
11
34
839
8500
29
124
795
8185
50
206
677
7060
Persistent somatoform pain disorder
F45.4 [45605498]
F45.4 [45605498]
1.8e+00
2.0e+00
—
—
—
—
1.7e+00
cases:0.82%
controls:0.14%
cases:0.70%
controls:0.09%
—
—
—
—
—
—
—
—
cases:0.69%
controls:0.12%
7
12
849
8538
6
8
850
8542
—
—
—
—
5
9
722
7257
Pain localized to other parts of lower abdomen
R10.3 [45534426]
R10.3 [45534426]
8.4e-01
8.7e-01
—
—
—
8.5e-01
1.2e+00
cases:7.71%
controls:3.50%
cases:2.45%
controls:1.04%
—
—
—
—
—
—
cases:2.43%
controls:1.05%
cases:11.28%
controls:3.66%
66
299
790
8251
21
89
835
8461
—
—
—
20
87
804
8222
82
266
645
7000
Unspecified fall
W19 [45756257]
W19 [45756257]
1.2e+00
1.6e+00
—
1.0e+50
—
1.0e+00
9.9e-01
cases:2.80%
controls:0.87%
cases:1.17%
controls:0.25%
—
—
cases:2.80%
controls:0.00%
—
—
cases:0.73%
controls:0.26%
cases:2.34%
controls:0.88%
24
74
832
8476
10
21
846
8529
—
24
0
832
8550
—
6
22
818
8287
17
64
710
7202
Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
21573-1 [3003031]
21573-1 [3003031]
7.6e-01
1.1e+00
—
—
1.7e+00
1.2e+00
7.2e-01
cases:4.91%
controls:2.35%
cases:2.10%
controls:0.71%
—
—
—
—
cases:0.59%
controls:0.11%
cases:2.91%
controls:0.93%
cases:6.19%
controls:3.12%
42
201
814
8349
18
61
838
8489
—
—
5
9
845
8525
24
77
800
8232
45
227
682
7039
Psychological sympt/compl other
P29 [2002000823]
P29 [2002000823]
1.2e+00
1.1e+00
—
—
1.4e+00
1.5e+00
1.0e+00
cases:2.80%
controls:0.83%
cases:1.40%
controls:0.46%
—
—
—
—
cases:0.59%
controls:0.14%
cases:2.06%
controls:0.47%
cases:3.85%
controls:1.46%
24
71
832
8479
12
39
844
8511
—
—
5
12
845
8522
17
39
807
8270
28
106
699
7160
ibuprofen
R02AX02 [1588667]
R02AX02 [1588667]
4.1e-01
5.0e-01
5.2e-01
—
1.8e+00
5.4e-01
4.9e-01
cases:43.34%
controls:33.66%
cases:22.55%
controls:15.04%
cases:3.27%
controls:1.98%
—
—
cases:10.12%
controls:1.85%
cases:24.15%
controls:15.68%
cases:48.83%
controls:36.84%
371
2878
485
5672
193
1286
663
7264
28
169
828
8381
—
86
158
764
8376
199
1303
625
7006
355
2677
372
4589
ibuprofen; oral, parenteral, rectal
M01AE01 [21603967]
M01AE01 [21603967]
4.1e-01
5.0e-01
5.2e-01
—
1.8e+00
5.4e-01
4.9e-01
cases:43.34%
controls:33.66%
cases:22.55%
controls:15.04%
cases:3.27%
controls:1.98%
—
—
cases:10.12%
controls:1.85%
cases:24.15%
controls:15.68%
cases:48.83%
controls:36.84%
371
2878
485
5672
193
1286
663
7264
28
169
828
8381
—
86
158
764
8376
199
1303
625
7006
355
2677
372
4589
tizanidine; oral
M03BX02 [21604116]
M03BX02 [21604116]
6.3e-01
6.8e-01
6.8e-01
—
1.9e+00
3.1e-01
4.9e-01
cases:19.86%
controls:11.65%
cases:7.59%
controls:4.01%
cases:1.05%
controls:0.54%
—
—
cases:2.94%
controls:0.45%
cases:5.22%
controls:3.88%
cases:18.98%
controls:12.57%
170
996
686
7554
65
343
791
8207
9
46
847
8504
—
25
38
825
8496
43
322
781
7987
138
913
589
6353
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
6768-6 [3035995]
3.2e-01
4.5e-01
9.5e-01
—
7.9e-01
5.9e-01
6.0e-01
cases:18.34%
controls:13.98%
cases:12.03%
controls:8.00%
cases:3.86%
controls:1.52%
—
—
cases:3.06%
controls:1.42%
cases:13.83%
controls:8.16%
cases:29.30%
controls:18.55%
157
1195
699
7355
103
684
753
7866
33
130
823
8420
—
26
121
824
8413
114
678
710
7631
213
1348
514
5918
Viral disease other/NOS
A77 [2002000211]
A77 [2002000211]
1.4e+00
2.3e+00
—
—
—
—
5.4e-01
cases:1.40%
controls:0.35%
cases:0.70%
controls:0.07%
—
—
—
—
—
—
—
—
cases:0.83%
controls:0.48%
12
30
844
8520
6
6
850
8544
—
—
—
—
6
35
721
7231
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
1742-6 [3006923]
1.8e-01
2.6e-01
7.8e-01
1.9e+00
7.0e-01
3.2e-01
2.4e-01
cases:29.44%
controls:25.87%
cases:21.85%
controls:17.77%
cases:6.31%
controls:3.01%
cases:0.82%
controls:0.13%
cases:5.76%
controls:2.94%
cases:23.18%
controls:18.03%
cases:42.92%
controls:37.13%
252
2212
604
6338
187
1519
669
7031
54
257
802
8293
7
11
849
8539
49
251
801
8283
191
1498
633
6811
312
2698
415
4568
Syncope and collapse
R55 [45568141]
R55 [45568141]
1.1e+00
1.6e+00
—
—
—
1.6e+00
9.6e-01
cases:2.22%
controls:0.78%
cases:1.05%
controls:0.21%
—
—
—
—
—
—
cases:0.85%
controls:0.17%
cases:2.61%
controls:1.02%
19
67
837
8483
9
18
847
8532
—
—
—
7
14
817
8295
19
74
708
7192
Other and unspecified abdominal pain
R10.4 [45568113]
R10.4 [45568113]
8.0e-01
7.8e-01
1.3e+00
—
1.4e+00
1.1e+00
9.8e-01
cases:11.33%
controls:5.42%
cases:3.62%
controls:1.70%
cases:0.70%
controls:0.19%
—
—
cases:1.06%
controls:0.27%
cases:5.22%
controls:1.89%
cases:14.72%
controls:6.11%
97
463
759
8087
31
145
825
8405
6
16
850
8534
—
9
23
841
8511
43
157
781
8152
107
444
620
6822
Low back pain
M54.5 [45553207]
M54.5 [45553207]
8.1e-01
1.2e+00
1.3e+00
—
9.2e-01
7.7e-01
8.2e-01
cases:9.46%
controls:4.46%
cases:4.32%
controls:1.33%
cases:0.70%
controls:0.19%
—
—
cases:0.59%
controls:0.23%
cases:3.64%
controls:1.72%
cases:13.34%
controls:6.34%
81
381
775
8169
37
114
819
8436
6
16
850
8534
—
5
20
845
8514
30
143
794
8166
97
461
630
6805
Asthma, unspecified
J45.9 [45562456]
J45.9 [45562456]
7.9e-01
9.5e-01
—
—
—
9.5e-01
8.5e-01
cases:4.79%
controls:2.22%
cases:2.80%
controls:1.10%
—
—
—
—
—
—
cases:2.79%
controls:1.10%
cases:6.33%
controls:2.81%
41
190
815
8360
24
94
832
8456
—
—
—
23
91
801
8218
46
204
681
7062
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
14631-6 [3006140]
4.7e-01
6.7e-01
8.8e-01
—
1.1e+00
6.4e-01
6.4e-01
cases:11.45%
controls:7.49%
cases:6.89%
controls:3.64%
cases:1.75%
controls:0.74%
—
—
cases:2.35%
controls:0.79%
cases:6.80%
controls:3.69%
cases:17.47%
controls:10.03%
98
640
758
7910
59
311
797
8239
15
63
841
8487
—
20
67
830
8467
56
307
768
8002
127
729
600
6537
lithium; oral
N05AN01 [21604556]
N05AN01 [21604556]
1.7e+00
1.8e+00
—
—
—
1.6e+00
1.3e+00
cases:1.40%
controls:0.27%
cases:0.93%
controls:0.15%
—
—
—
—
—
—
cases:0.73%
controls:0.14%
cases:0.96%
controls:0.28%
12
23
844
8527
8
13
848
8537
—
—
—
6
12
818
8297
7
20
720
7246
chlorprothixene; oral, parenteral
N05AF03 [21604533]
N05AF03 [21604533]
1.4e+00
1.3e+00
—
—
—
—
2.1e+00
cases:1.17%
controls:0.29%
cases:0.58%
controls:0.16%
—
—
—
—
—
—
—
—
cases:1.93%
controls:0.25%
10
25
846
8525
5
14
851
8536
—
—
—
—
14
18
713
7248
Feeling anxious/nervous/tense
P01 [2002000798]
P01 [2002000798]
7.3e-01
8.9e-01
—
—
1.2e+00
1.0e+00
7.6e-01
cases:5.14%
controls:2.54%
cases:2.45%
controls:1.02%
—
—
—
—
cases:0.71%
controls:0.21%
cases:2.79%
controls:1.02%
cases:6.60%
controls:3.19%
44
217
812
8333
21
87
835
8463
—
—
6
18
844
8516
23
85
801
8224
48
232
679
7034
UNS Panic Syndrome
F41.09 [2000501997]
F41.09 [2000501997]
1.7e+00
1.7e+00
—
—
—
1.9e+00
1.7e+00
cases:1.29%
controls:0.23%
cases:0.58%
controls:0.11%
—
—
—
—
—
—
cases:0.73%
controls:0.11%
cases:1.51%
controls:0.29%
11
20
845
8530
5
9
851
8541
—
—
—
6
9
818
8300
11
21
716
7245
Essential (primary) hypertension
I10 [45591453]
I10 [45591453]
2.2e-01
1.5e-01
3.8e-01
3.3e+00
7.0e-01
3.1e-01
3.0e-01
cases:9.93%
controls:8.13%
cases:4.91%
controls:4.25%
cases:0.93%
controls:0.64%
cases:1.52%
controls:0.06%
cases:1.18%
controls:0.59%
cases:5.83%
controls:4.34%
cases:14.03%
controls:10.75%
85
695
771
7855
42
363
814
8187
8
55
848
8495
13
5
843
8545
10
50
840
8484
48
361
776
7948
102
781
625
6485
escitalopram; oral
N06AB10 [21604718]
N06AB10 [21604718]
7.1e-01
8.3e-01
7.0e-01
—
8.9e-01
9.6e-01
7.5e-01
cases:7.59%
controls:3.87%
cases:4.67%
controls:2.09%
cases:1.05%
controls:0.53%
—
—
cases:1.53%
controls:0.63%
cases:5.46%
controls:2.17%
cases:9.22%
controls:4.58%
65
331
791
8219
40
179
816
8371
9
45
847
8505
—
13
54
837
8480
45
180
779
8129
67
333
660
6933
Lower leg X-ray examination
NG4AA [2001308083]
NG4AA [2001308083]
1.7e+00
—
—
—
—
—
1.6e+00
cases:1.05%
controls:0.20%
—
—
—
—
—
—
—
—
—
—
cases:1.38%
controls:0.29%
9
17
847
8533
—
—
—
—
—
10
21
717
7245
Acute vaginitis
N76.0 [45543891]
N76.0 [45543891]
6.0e-01
1.7e+00
—
—
—
1.6e+00
5.4e-01
cases:1.75%
controls:0.97%
cases:1.17%
controls:0.22%
—
—
—
—
—
—
cases:1.09%
controls:0.23%
cases:1.93%
controls:1.13%
15
83
841
8467
10
19
846
8531
—
—
—
9
19
815
8290
14
82
713
7184
propranolol; oral, parenteral
C07AA05 [21601670]
C07AA05 [21601670]
7.0e-01
1.0e+00
1.1e+00
—
9.0e-01
7.3e-01
7.4e-01
cases:8.41%
controls:4.35%
cases:5.02%
controls:1.89%
cases:0.82%
controls:0.28%
—
—
cases:1.06%
controls:0.43%
cases:4.37%
controls:2.15%
cases:8.80%
controls:4.42%
72
372
784
8178
43
162
813
8388
7
24
849
8526
—
9
37
841
8497
36
179
788
8130
64
321
663
6945
amitriptyline; oral, parenteral
N06AA09 [21604696]
N06AA09 [21604696]
5.7e-01
7.6e-01
6.3e-01
—
7.0e-01
8.1e-01
1.0e+00
cases:5.26%
controls:3.04%
cases:3.04%
controls:1.45%
cases:0.70%
controls:0.37%
—
—
cases:0.71%
controls:0.35%
cases:2.79%
controls:1.26%
cases:8.12%
controls:3.07%
45
260
811
8290
26
124
830
8426
6
32
850
8518
—
6
30
844
8504
23
105
801
8204
59
223
668
7043
Contusion of knee
S80.0 [45569633]
S80.0 [45569633]
1.4e+00
1.3e+00
—
1.0e+50
—
1.7e+00
7.4e-01
cases:2.69%
controls:0.65%
cases:0.93%
controls:0.27%
—
—
cases:1.87%
controls:0.00%
—
—
cases:1.46%
controls:0.26%
cases:2.20%
controls:1.06%
23
56
833
8494
8
23
848
8527
—
16
0
840
8550
—
12
22
812
8287
16
77
711
7189
Adaptation disorder with mixed anxiety and depression
F43.22 [2000502003]
F43.22 [2000502003]
1.6e+00
1.0e+00
—
—
—
—
1.5e+00
cases:1.52%
controls:0.30%
cases:0.58%
controls:0.21%
—
—
—
—
—
—
—
—
cases:1.93%
controls:0.43%
13
26
843
8524
5
18
851
8532
—
—
—
—
14
31
713
7235
Amphetamines [Presence] in Urine
3349-8 [3027944]
3349-8 [3027944]
8.7e-01
1.2e+00
—
—
—
9.3e-01
1.1e+00
cases:3.04%
controls:1.30%
cases:1.75%
controls:0.54%
—
—
—
—
—
—
cases:1.33%
controls:0.53%
cases:5.23%
controls:1.87%
26
111
830
8439
15
46
841
8504
—
—
—
11
44
813
8265
38
136
689
7130
mirtazapine; oral
N06AX11 [21604740]
N06AX11 [21604740]
7.5e-01
8.1e-01
7.5e-01
—
4.1e-01
8.6e-01
6.9e-01
cases:10.28%
controls:5.16%
cases:5.72%
controls:2.62%
cases:1.52%
controls:0.73%
—
—
cases:1.06%
controls:0.70%
cases:6.31%
controls:2.78%
cases:12.24%
controls:6.54%
88
441
768
8109
49
224
807
8326
13
62
843
8488
—
9
60
841
8474
52
231
772
8078
89
475
638
6791
Internal Medicine
11 [38004456]
11 [38004456]
4.4e-01
4.5e-01
7.7e-01
—
6.1e-01
7.0e-01
7.4e-01
cases:23.95%
controls:16.83%
cases:10.28%
controls:6.80%
cases:2.80%
controls:1.32%
—
—
cases:2.00%
controls:1.10%
cases:12.99%
controls:6.91%
cases:28.61%
controls:15.99%
205
1439
651
7111
88
581
768
7969
24
113
832
8437
—
17
94
833
8440
107
574
717
7735
208
1162
519
6104
Folate [Moles/volume] in Serum or Plasma
14732-2 [3021960]
14732-2 [3021960]
5.5e-01
1.2e+00
—
—
1.9e+00
1.6e-01
5.0e-01
cases:3.04%
controls:1.78%
cases:3.15%
controls:1.01%
—
—
—
—
cases:0.94%
controls:0.14%
cases:1.58%
controls:1.35%
cases:7.02%
controls:4.39%
26
152
830
8398
27
86
829
8464
—
—
8
12
842
8522
13
112
811
8197
51
319
676
6947
cefalexin; oral
J01DB01 [21602870]
J01DB01 [21602870]
4.9e-01
3.9e-01
4.4e-01
—
9.8e-01
5.1e-01
6.9e-01
cases:38.43%
controls:27.65%
cases:12.27%
controls:8.63%
cases:1.52%
controls:0.98%
—
—
cases:2.71%
controls:1.03%
cases:13.35%
controls:8.45%
cases:41.95%
controls:26.58%
329
2364
527
6186
105
738
751
7812
13
84
843
8466
—
23
88
827
8446
110
702
714
7607
305
1931
422
5335
Physiotherapy
R4110 [2001310233]
R4110 [2001310233]
3.1e-01
6.0e-02
—
—
2.1e+00
7.7e-01
9.5e-01
cases:4.67%
controls:3.47%
cases:1.40%
controls:1.32%
—
—
—
—
cases:1.18%
controls:0.15%
cases:2.31%
controls:1.08%
cases:7.29%
controls:2.96%
40
297
816
8253
12
113
844
8437
—
—
10
13
840
8521
19
90
805
8219
53
215
674
7051
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
14749-6 [3013826]
3.3e-01
4.0e-01
1.6e+00
1.0e+50
9.5e-01
6.6e-01
6.6e-01
cases:12.85%
controls:9.56%
cases:6.43%
controls:4.42%
cases:2.69%
controls:0.54%
cases:4.21%
controls:0.00%
cases:1.53%
controls:0.60%
cases:7.77%
controls:4.18%
cases:20.50%
controls:11.81%
110
817
746
7733
55
378
801
8172
23
46
833
8504
36
0
820
8550
13
51
837
8483
64
347
760
7962
149
858
578
6408
Bipolar affective disorder, unspecified
F31.9 [45571758]
F31.9 [45571758]
1.5e+00
1.8e+00
—
—
—
1.8e+00
1.5e+00
cases:1.29%
controls:0.29%
cases:0.70%
controls:0.12%
—
—
—
—
—
—
cases:0.73%
controls:0.12%
cases:1.51%
controls:0.36%
11
25
845
8525
6
10
850
8540
—
—
—
6
10
818
8299
11
26
716
7240
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
51480-2 [3031040]
3.9e-01
4.7e-01
9.7e-01
1.0e+50
7.6e-01
5.7e-01
5.4e-01
cases:17.76%
controls:12.81%
cases:9.81%
controls:6.39%
cases:2.34%
controls:0.90%
cases:1.17%
controls:0.00%
cases:1.76%
controls:0.83%
cases:9.95%
controls:5.89%
cases:23.93%
controls:15.52%
152
1095
704
7455
84
546
772
8004
20
77
836
8473
10
0
846
8550
15
71
835
8463
82
489
742
7820
174
1128
553
6138
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
5894-1 [3033658]
3.2e-01
-1.5e-01
1.1e+00
—
2.1e+00
6.5e-01
8.1e-01
cases:5.26%
controls:3.86%
cases:1.52%
controls:1.77%
cases:0.58%
controls:0.19%
—
—
cases:1.18%
controls:0.15%
cases:3.03%
controls:1.60%
cases:8.94%
controls:4.17%
45
330
811
8220
13
151
843
8399
5
16
851
8534
—
10
13
840
8521
25
133
799
8176
65
303
662
6963
Acute bronchitis, unspecified
J20.9 [45562445]
J20.9 [45562445]
8.0e-01
1.0e+00
-1.0e+50
—
—
1.0e+00
1.0e+00
cases:3.97%
controls:1.82%
cases:1.75%
controls:0.64%
cases:0.00%
controls:0.07%
—
—
—
—
cases:1.46%
controls:0.53%
cases:5.23%
controls:1.90%
34
156
822
8394
15
55
841
8495
0
6
856
8544
—
—
12
44
812
8265
38
138
689
7128
Choriogonadotropin [Units/volume] in Urine
25372-4 [3023511]
25372-4 [3023511]
7.6e-01
1.3e+00
—
—
—
1.7e+00
1.2e+00
cases:1.75%
controls:0.83%
cases:0.93%
controls:0.25%
—
—
—
—
—
—
cases:0.97%
controls:0.18%
cases:2.61%
controls:0.83%
15
71
841
8479
8
21
848
8529
—
—
—
8
15
816
8294
19
60
708
7206
Upper respiratory infection acute
R74 [2002000942]
R74 [2002000942]
6.0e-01
7.1e-01
1.0e+00
—
—
9.3e-01
6.1e-01
cases:12.03%
controls:6.96%
cases:5.02%
controls:2.53%
cases:0.58%
controls:0.21%
—
—
—
—
cases:6.07%
controls:2.48%
cases:13.76%
controls:7.98%
103
595
753
7955
43
216
813
8334
5
18
851
8532
—
—
50
206
774
8103
100
580
627
6686
oxycodone and naloxone; oral
N02AA55 [21604265]
N02AA55 [21604265]
9.4e-01
1.2e+00
—
—
1.9e+00
6.9e-01
7.3e-01
cases:2.80%
controls:1.11%
cases:1.52%
controls:0.47%
—
—
—
—
cases:0.71%
controls:0.11%
cases:1.33%
controls:0.67%
cases:3.71%
controls:1.83%
24
95
832
8455
13
40
843
8510
—
—
6
9
844
8525
11
56
813
8253
27
133
700
7133
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
19072-8 [3016431]
4.9e-01
5.8e-01
1.1e+00
—
9.5e-01
5.2e-01
6.3e-01
cases:10.51%
controls:6.74%
cases:5.96%
controls:3.44%
cases:1.64%
controls:0.53%
—
—
cases:1.18%
controls:0.46%
cases:5.58%
controls:3.41%
cases:16.37%
controls:9.43%
90
576
766
7974
51
294
805
8256
14
45
842
8505
—
10
39
840
8495
46
283
778
8026
119
685
608
6581
Gastroenterology
10 [38004455]
10 [38004455]
6.2e-01
7.3e-01
5.4e-01
—
1.1e+00
7.1e-01
7.3e-01
cases:6.78%
controls:3.77%
cases:3.50%
controls:1.72%
cases:0.70%
controls:0.41%
—
—
cases:1.06%
controls:0.35%
cases:3.76%
controls:1.88%
cases:8.80%
controls:4.43%
58
322
798
8228
30
147
826
8403
6
35
850
8515
—
9
30
841
8504
31
156
793
8153
64
322
663
6944
ketoprofen; oral, parenteral, rectal
M01AE03 [21603969]
M01AE03 [21603969]
6.2e-01
2.6e-01
—
—
2.2e+00
4.4e-01
4.3e-01
cases:7.36%
controls:4.12%
cases:1.64%
controls:1.26%
—
—
—
—
cases:0.82%
controls:0.09%
cases:1.58%
controls:1.02%
cases:4.54%
controls:3.00%
63
352
793
8198
14
108
842
8442
—
—
7
8
843
8526
13
85
811
8224
33
218
694
7048
ECG with 12 standard connections
XF400 [2001303368]
XF400 [2001303368]
5.5e-01
1.0e+00
—
1.0e+50
—
1.7e+00
1.1e+00
cases:2.57%
controls:1.50%
cases:1.05%
controls:0.39%
—
—
cases:0.58%
controls:0.00%
—
—
cases:1.09%
controls:0.20%
cases:3.44%
controls:1.17%
22
128
834
8422
9
33
847
8517
—
5
0
851
8550
—
9
17
815
8292
25
85
702
7181
Pedal cyclist injured in other and unspecified transport accidents
V19 [45756225]
V19 [45756225]
—
—
—
—
—
—
2.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.10%
controls:0.07%
—
—
—
—
—
—
8
5
719
7261
Drug use
Z72.2 [45571385]
Z72.2 [45571385]
2.8e+00
—
—
—
—
—
—
cases:0.93%
controls:0.06%
—
—
—
—
—
—
—
—
—
—
—
—
8
5
848
8545
—
—
—
—
—
—
Person encountering health services in unspecified circumstances
Z76.9 [45609967]
Z76.9 [45609967]
8.6e-01
1.5e+00
-1.0e+50
—
—
1.0e+00
1.3e+00
cases:1.99%
controls:0.85%
cases:1.52%
controls:0.35%
cases:0.00%
controls:0.08%
—
—
—
—
cases:0.97%
controls:0.36%
cases:3.85%
controls:1.11%
17
73
839
8477
13
30
843
8520
0
7
856
8543
—
—
8
30
816
8279
28
81
699
7185
Crushed, pushed or stepped on by crowd or human stampede
W52 [45756303]
W52 [45756303]
—
—
—
1.0e+50
—
2.7e+00
—
—
—
—
—
—
—
cases:2.80%
controls:0.00%
—
—
cases:0.85%
controls:0.06%
—
—
—
—
—
24
0
832
8550
—
7
5
817
8304
—
Assault by bodily force by other known person
Y04.8 [2000503711]
Y04.8 [2000503711]
—
—
—
1.0e+50
1.0e+50
—
2.6e+00
—
—
—
—
—
—
cases:1.75%
controls:0.00%
cases:0.59%
controls:0.00%
—
—
cases:0.96%
controls:0.07%
—
—
—
15
0
841
8550
5
0
845
8534
—
7
5
720
7261
Contusion of other parts of wrist and hand
S60.2 [45602941]
S60.2 [45602941]
1.4e+00
—
—
1.0e+50
—
1.4e+00
1.3e+00
cases:1.52%
controls:0.39%
—
—
—
—
cases:1.64%
controls:0.00%
—
—
cases:0.61%
controls:0.16%
cases:2.20%
controls:0.63%
13
33
843
8517
—
—
14
0
842
8550
—
5
13
819
8296
16
46
711
7220
Assault by bodily force by unknown person
Y04.9 [2000503712]
Y04.9 [2000503712]
—
—
—
1.0e+50
—
—
2.6e+00
—
—
—
—
—
—
cases:1.99%
controls:0.00%
—
—
—
—
cases:1.51%
controls:0.11%
—
—
—
17
0
839
8550
—
—
11
8
716
7258
Feeling depressed
P03 [2002000800]
P03 [2002000800]
7.9e-01
8.6e-01
—
—
—
1.1e+00
7.1e-01
cases:3.50%
controls:1.63%
cases:1.40%
controls:0.60%
—
—
—
—
—
—
cases:2.18%
controls:0.73%
cases:4.13%
controls:2.06%
30
139
826
8411
12
51
844
8499
—
—
—
18
61
806
8248
30
150
697
7116
Sprain and strain of shoulder joint
S43.4 [45607418]
S43.4 [45607418]
9.2e-01
2.6e+00
—
—
—
—
8.8e-01
cases:0.58%
controls:0.23%
cases:0.93%
controls:0.07%
—
—
—
—
—
—
—
—
cases:0.83%
controls:0.34%
5
20
851
8530
8
6
848
8544
—
—
—
—
6
25
721
7241
Intentional self-harm by sharp object
X78 [45756450]
X78 [45756450]
2.6e+00
—
—
1.0e+50
—
—
—
cases:0.93%
controls:0.07%
—
—
—
—
cases:0.82%
controls:0.00%
—
—
—
—
—
—
8
6
848
8544
—
—
7
0
849
8550
—
—
—
Generalized anxiety disorder
F41.1 [45571764]
F41.1 [45571764]
4.4e-01
1.3e+00
—
—
2.3e+00
1.5e+00
1.0e+00
cases:1.29%
controls:0.83%
cases:1.17%
controls:0.32%
—
—
—
—
cases:0.59%
controls:0.06%
cases:1.46%
controls:0.32%
cases:2.61%
controls:0.95%
11
71
845
8479
10
27
846
8523
—
—
5
5
845
8529
12
27
812
8282
19
69
708
7197
Depressive disorder
P76 [2002000870]
P76 [2002000870]
1.0e+00
—
-1.0e+50
—
—
1.5e+00
7.0e-01
cases:2.69%
controls:0.97%
—
—
cases:0.00%
controls:0.09%
—
—
—
—
cases:1.70%
controls:0.39%
cases:2.06%
controls:1.03%
23
83
833
8467
—
0
8
856
8542
—
—
14
32
810
8277
15
75
712
7191
Pain in joint
M25.5 [45586941]
M25.5 [45586941]
7.0e-01
1.1e+00
—
—
—
5.3e-01
7.0e-01
cases:6.78%
controls:3.50%
cases:3.62%
controls:1.22%
—
—
—
—
—
—
cases:2.43%
controls:1.44%
cases:9.08%
controls:4.72%
58
299
798
8251
31
104
825
8446
—
—
—
20
120
804
8189
66
343
661
6923
Hospital outpatient
ZY010 [2001311599]
ZY010 [2001311599]
8.7e-01
4.9e-01
-1.0e+50
—
—
1.4e+00
1.1e+00
cases:2.10%
controls:0.89%
cases:0.82%
controls:0.50%
cases:0.00%
controls:0.19%
—
—
—
—
cases:1.33%
controls:0.34%
cases:1.79%
controls:0.59%
18
76
838
8474
7
43
849
8507
0
16
856
8534
—
—
11
28
813
8281
13
43
714
7223
Intracranial injury, unspecified
S06.9 [45549096]
S06.9 [45549096]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.83%
controls:0.07%
—
—
—
—
—
—
6
5
721
7261
Extensive initial psychiatric evaluation
IBA04 [2001304046]
IBA04 [2001304046]
1.8e+00
2.5e+00
—
—
—
—
8.7e-01
cases:0.58%
controls:0.09%
cases:0.70%
controls:0.06%
—
—
—
—
—
—
—
—
cases:0.69%
controls:0.29%
5
8
851
8542
6
5
850
8545
—
—
—
—
5
21
722
7245
aciclovir; oral, parenteral
J05AB01 [21603131]
J05AB01 [21603131]
7.1e-01
1.1e+00
1.4e+00
—
1.7e+00
7.9e-01
7.0e-01
cases:4.79%
controls:2.42%
cases:2.69%
controls:0.94%
cases:0.58%
controls:0.14%
—
—
cases:0.59%
controls:0.11%
cases:2.31%
controls:1.06%
cases:5.78%
controls:2.96%
41
207
815
8343
23
80
833
8470
5
12
851
8538
—
5
9
845
8525
19
88
805
8221
42
215
685
7051
Burn/scald
S14 [2002000979]
S14 [2002000979]
1.4e+00
—
—
—
—
2.5e+00
6.6e-01
cases:0.82%
controls:0.20%
—
—
—
—
—
—
—
—
cases:0.85%
controls:0.07%
cases:0.69%
controls:0.36%
7
17
849
8533
—
—
—
—
7
6
817
8303
5
26
722
7240
Knee X-ray examination without contrast
NG1AA [2001308049]
NG1AA [2001308049]
7.6e-01
1.5e+00
—
—
—
—
9.8e-01
cases:1.99%
controls:0.94%
cases:1.52%
controls:0.35%
—
—
—
—
—
—
—
—
cases:2.20%
controls:0.84%
17
80
839
8470
13
30
843
8520
—
—
—
—
16
61
711
7205
Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
49376-7 [3029536]
49376-7 [3029536]
—
—
—
—
—
—
2.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.10%
controls:0.10%
—
—
—
—
—
—
8
7
719
7259
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
F19.1 [45552459]
F19.1 [45552459]
2.4e+00
—
—
—
—
—
—
cases:0.93%
controls:0.08%
—
—
—
—
—
—
—
—
—
—
—
—
8
7
848
8543
—
—
—
—
—
—
risperidone; oral, parenteral
N05AX08 [21604559]
N05AX08 [21604559]
9.1e-01
8.4e-01
1.4e+00
—
1.2e+00
1.3e+00
1.1e+00
cases:1.75%
controls:0.71%
cases:1.05%
controls:0.46%
cases:0.58%
controls:0.14%
—
—
cases:0.82%
controls:0.25%
cases:2.18%
controls:0.60%
cases:2.75%
controls:0.91%
15
61
841
8489
9
39
847
8511
5
12
851
8538
—
7
21
843
8513
18
50
806
8259
20
66
707
7200
Superficial injury of scalp
S00.0 [45548998]
S00.0 [45548998]
2.4e+00
—
—
1.0e+50
—
—
1.4e+00
cases:1.05%
controls:0.09%
—
—
—
—
cases:1.40%
controls:0.00%
—
—
—
—
cases:0.69%
controls:0.18%
9
8
847
8542
—
—
12
0
844
8550
—
—
5
13
722
7253
Recurrent depressive disorder, current episode severe without psychotic symptoms
F33.2 [45547705]
F33.2 [45547705]
1.4e+00
1.2e+00
—
—
1.8e+00
7.5e-01
1.0e+00
cases:2.10%
controls:0.54%
cases:1.29%
controls:0.39%
—
—
—
—
cases:0.71%
controls:0.12%
cases:0.61%
controls:0.29%
cases:1.93%
controls:0.69%
18
46
838
8504
11
33
845
8517
—
—
6
10
844
8524
5
24
819
8285
14
50
713
7216
Alcohol dependence continuous use
F10.25 [2000501682]
F10.25 [2000501682]
—
—
—
—
—
—
2.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.38%
controls:0.12%
—
—
—
—
—
—
10
9
717
7257
azithromycin; oral, parenteral
J01FA10 [21602978]
J01FA10 [21602978]
4.5e-01
6.5e-01
—
—
—
6.3e-01
6.6e-01
cases:14.49%
controls:9.75%
cases:4.67%
controls:2.50%
—
—
—
—
—
—
cases:4.25%
controls:2.30%
cases:12.93%
controls:7.10%
124
834
732
7716
40
214
816
8336
—
—
—
35
191
789
8118
94
516
633
6750
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
6598-7 [3019800]
4.6e-01
7.3e-01
1.2e+00
1.0e+50
—
8.2e-01
8.4e-01
cases:6.89%
controls:4.48%
cases:3.97%
controls:1.95%
cases:0.70%
controls:0.21%
cases:2.22%
controls:0.00%
—
—
cases:4.25%
controls:1.91%
cases:13.34%
controls:6.23%
59
383
797
8167
34
167
822
8383
6
18
850
8532
19
0
837
8550
—
35
159
789
8150
97
453
630
6813
zolpidem; oral
N05CF02 [21604655]
N05CF02 [21604655]
7.2e-01
7.0e-01
1.5e+00
—
1.6e+00
7.2e-01
4.6e-01
cases:4.56%
controls:2.27%
cases:2.45%
controls:1.23%
cases:0.82%
controls:0.19%
—
—
cases:1.18%
controls:0.23%
cases:2.67%
controls:1.32%
cases:4.13%
controls:2.64%
39
194
817
8356
21
105
835
8445
7
16
849
8534
—
10
20
840
8514
22
110
802
8199
30
192
697
7074
Dizziness and giddiness
R42 [45568132]
R42 [45568132]
4.4e-01
1.1e+00
—
—
—
1.2e+00
6.0e-01
cases:3.39%
controls:2.20%
cases:1.75%
controls:0.58%
—
—
—
—
—
—
cases:1.94%
controls:0.58%
cases:3.99%
controls:2.23%
29
188
827
8362
15
50
841
8500
—
—
—
16
48
808
8261
29
162
698
7104
Acute alcohol abuse
P16 [2002000812]
P16 [2002000812]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.38%
controls:0.14%
—
—
—
—
—
—
10
10
717
7256
Neck symptom/complaint
L01 [2002000626]
L01 [2002000626]
4.4e-01
1.3e+00
—
—
2.3e+00
6.9e-01
3.4e-01
cases:2.45%
controls:1.59%
cases:1.29%
controls:0.36%
—
—
—
—
cases:0.71%
controls:0.07%
cases:1.46%
controls:0.73%
cases:2.89%
controls:2.08%
21
136
835
8414
11
31
845
8519
—
—
6
6
844
8528
12
61
812
8248
21
151
706
7115
Unspecified injury of head
S09.9 [45602140]
S09.9 [45602140]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.10%
controls:0.11%
—
—
—
—
—
—
8
8
719
7258
Motorcycle rider [any] injured in unspecified traffic accident
V29.9 [45546833]
V29.9 [45546833]
—
—
—
1.0e+50
—
—
2.3e+00
—
—
—
—
—
—
cases:0.82%
controls:0.00%
—
—
—
—
cases:0.96%
controls:0.10%
—
—
—
7
0
849
8550
—
—
7
7
720
7259
Exposure to other and unspecified inanimate mechanical forces
W49 [45756300]
W49 [45756300]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.96%
controls:0.10%
—
—
—
—
—
—
7
7
720
7259
naltrexone; oral
N07BB04 [21604824]
N07BB04 [21604824]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.83%
controls:0.08%
—
—
—
—
—
—
6
6
721
7260
Acetaminophen [Moles/volume] in Serum or Plasma
14581-3 [3020485]
14581-3 [3020485]
2.3e+00
—
—
—
—
—
—
cases:0.82%
controls:0.08%
—
—
—
—
—
—
—
—
—
—
—
—
7
7
849
8543
—
—
—
—
—
—
prednisolone
A07EA01 [21600653]
A07EA01 [21600653]
8.0e-01
4.8e-01
1.8e-01
—
6.2e-01
7.1e-01
8.0e-01
cases:15.30%
controls:7.54%
cases:4.44%
controls:2.80%
cases:0.70%
controls:0.58%
—
—
cases:0.82%
controls:0.45%
cases:6.19%
controls:3.14%
cases:15.68%
controls:7.69%
131
645
725
7905
38
239
818
8311
6
50
850
8500
—
7
38
843
8496
51
261
773
8048
114
559
613
6707
alprazolam; oral
N05BA12 [21604577]
N05BA12 [21604577]
1.2e+00
1.1e+00
—
—
—
9.3e-01
8.3e-01
cases:3.04%
controls:0.90%
cases:1.75%
controls:0.61%
—
—
—
—
—
—
cases:1.33%
controls:0.53%
cases:2.06%
controls:0.91%
26
77
830
8473
15
52
841
8498
—
—
—
11
44
813
8265
15
66
712
7200
prednisolone; oral, parenteral
H02AB06 [21602734]
H02AB06 [21602734]
7.9e-01
4.8e-01
1.8e-01
—
6.2e-01
6.9e-01
8.0e-01
cases:15.19%
controls:7.49%
cases:4.44%
controls:2.80%
cases:0.70%
controls:0.58%
—
—
cases:0.82%
controls:0.45%
cases:6.07%
controls:3.13%
cases:15.54%
controls:7.62%
130
640
726
7910
38
239
818
8311
6
50
850
8500
—
7
38
843
8496
50
260
774
8049
113
554
614
6712
Hand/finger symptom/complaint
L12 [2002000636]
L12 [2002000636]
1.0e+00
4.7e-01
—
—
—
1.2e+00
6.0e-01
cases:5.37%
controls:2.00%
cases:0.82%
controls:0.51%
—
—
—
—
—
—
cases:1.58%
controls:0.46%
cases:3.85%
controls:2.16%
46
171
810
8379
7
44
849
8506
—
—
—
13
38
811
8271
28
157
699
7109
Pain localized to upper abdomen
R10.1 [45568111]
R10.1 [45568111]
4.8e-01
1.4e+00
—
—
—
9.3e-01
8.8e-01
cases:2.92%
controls:1.82%
cases:1.52%
controls:0.39%
—
—
—
—
—
—
cases:1.33%
controls:0.53%
cases:4.95%
controls:2.12%
25
156
831
8394
13
33
843
8517
—
—
—
11
44
813
8265
36
154
691
7112
salbutamol; inhalant
R03AC02 [21603256]
R03AC02 [21603256]
5.6e-01
4.7e-01
4.4e-01
—
3.4e-01
6.4e-01
5.8e-01
cases:19.98%
controls:12.51%
cases:9.23%
controls:5.98%
cases:1.52%
controls:0.98%
—
—
cases:1.53%
controls:1.09%
cases:10.80%
controls:6.01%
cases:22.01%
controls:13.60%
171
1070
685
7480
79
511
777
8039
13
84
843
8466
—
13
93
837
8441
89
499
735
7810
160
988
567
6278
Monocytes/Leukocytes in Blood
26485-3 [3019069]
26485-3 [3019069]
4.3e-01
4.9e-01
9.3e-01
—
3.3e-01
3.7e-01
3.9e-01
cases:12.62%
controls:8.57%
cases:7.71%
controls:4.85%
cases:2.57%
controls:1.03%
—
—
cases:1.41%
controls:1.02%
cases:7.04%
controls:4.98%
cases:15.27%
controls:10.91%
108
733
748
7817
66
415
790
8135
22
88
834
8462
—
12
87
838
8447
58
414
766
7895
111
793
616
6473
Other sleep disorders
G47.8 [45581501]
G47.8 [45581501]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.65%
controls:0.18%
—
—
—
—
—
—
12
13
715
7253
Cathetrisation of vein
TPH04 [2001309597]
TPH04 [2001309597]
5.1e-01
7.0e-01
—
1.0e+50
—
1.2e+00
9.7e-01
cases:3.27%
controls:2.00%
cases:1.29%
controls:0.64%
—
—
cases:1.05%
controls:0.00%
—
—
cases:1.82%
controls:0.54%
cases:5.50%
controls:2.16%
28
171
828
8379
11
55
845
8495
—
9
0
847
8550
—
15
45
809
8264
40
157
687
7109
Facial pain NOS
R51.81 [2000503604]
R51.81 [2000503604]
-1.0e+50
—
—
—
—
—
2.2e+00
cases:0.00%
controls:0.12%
—
—
—
—
—
—
—
—
—
—
cases:1.10%
controls:0.12%
0
10
856
8540
—
—
—
—
—
8
9
719
7257
Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium
O99.3 [45606675]
O99.3 [45606675]
—
-1.0e+50
—
—
—
—
2.2e+00
—
—
cases:0.00%
controls:0.06%
—
—
—
—
—
—
—
—
cases:1.10%
controls:0.12%
—
0
5
856
8545
—
—
—
—
8
9
719
7257
Mixed personality disorders
F61.0 [2000502024]
F61.0 [2000502024]
2.2e+00
—
—
—
—
—
—
cases:0.93%
controls:0.11%
—
—
—
—
—
—
—
—
—
—
—
—
8
9
848
8541
—
—
—
—
—
—
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
26478-8 [3002030]
4.2e-01
4.7e-01
9.3e-01
—
3.0e-01
3.2e-01
3.7e-01
cases:12.85%
controls:8.87%
cases:7.83%
controls:5.02%
cases:2.57%
controls:1.03%
—
—
cases:1.41%
controls:1.05%
cases:7.16%
controls:5.28%
cases:15.82%
controls:11.49%
110
758
746
7792
67
429
789
8121
22
88
834
8462
—
12
90
838
8444
59
439
765
7870
115
835
612
6431
Pain in limb
M79.6 [45587063]
M79.6 [45587063]
6.3e-01
5.7e-01
—
—
—
8.3e-01
7.3e-01
cases:8.41%
controls:4.67%
cases:3.27%
controls:1.88%
—
—
—
—
—
—
cases:4.49%
controls:2.01%
cases:14.03%
controls:7.32%
72
399
784
8151
28
161
828
8389
—
—
—
37
167
787
8142
102
532
625
6734
Skin symptom/complaint other
S29 [2002000993]
S29 [2002000993]
4.7e-01
1.3e+00
—
—
—
-1.8e-01
9.1e-01
cases:3.15%
controls:2.00%
cases:1.64%
controls:0.47%
—
—
—
—
—
—
cases:0.61%
controls:0.72%
cases:5.23%
controls:2.17%
27
171
829
8379
14
40
842
8510
—
—
—
5
60
819
8249
38
158
689
7108
Migraine with aura [classical migraine]
G43.1 [45562086]
G43.1 [45562086]
5.5e-01
6.2e-01
—
1.0e+50
2.2e+00
8.9e-01
6.6e-01
cases:1.87%
controls:1.09%
cases:0.93%
controls:0.50%
—
—
cases:0.70%
controls:0.00%
cases:0.71%
controls:0.08%
cases:1.33%
controls:0.55%
cases:2.48%
controls:1.29%
16
93
840
8457
8
43
848
8507
—
6
0
850
8550
6
7
844
8527
11
46
813
8263
18
94
709
7172
Thoracal spine MRI examination with high intensity magnet
NA2BG [2001307013]
NA2BG [2001307013]
-1.0e+50
—
—
—
—
—
2.2e+00
cases:0.00%
controls:0.14%
—
—
—
—
—
—
—
—
—
—
cases:0.83%
controls:0.10%
0
12
856
8538
—
—
—
—
—
6
7
721
7259
Procedure duration 120 to 149 minutes
ZXE15 [2001311406]
ZXE15 [2001311406]
1.1e+00
-1.0e+50
—
—
—
—
2.2e+00
cases:0.58%
controls:0.19%
cases:0.00%
controls:0.09%
—
—
—
—
—
—
—
—
cases:0.83%
controls:0.10%
5
16
851
8534
0
8
856
8542
—
—
—
—
6
7
721
7259
Gas panel - Venous blood
24339-4 [3000991]
24339-4 [3000991]
-2.8e-01
5.6e-01
2.2e+00
—
—
3.4e-01
7.7e-01
cases:0.82%
controls:1.08%
cases:0.93%
controls:0.54%
cases:0.70%
controls:0.08%
—
—
—
—
cases:0.73%
controls:0.52%
cases:3.16%
controls:1.49%
7
92
849
8458
8
46
848
8504
6
7
850
8543
—
—
6
43
818
8266
23
108
704
7158
Personality disorder, unspecified
F60.9 [45538076]
F60.9 [45538076]
2.2e+00
—
—
—
—
—
—
cases:0.70%
controls:0.08%
—
—
—
—
—
—
—
—
—
—
—
—
6
7
850
8543
—
—
—
—
—
—
tranexamic acid; oral, parenteral
B02AA02 [21601036]
B02AA02 [21601036]
8.6e-01
8.4e-01
—
—
—
1.3e+00
6.6e-01
cases:3.50%
controls:1.51%
cases:1.05%
controls:0.46%
—
—
—
—
—
—
cases:1.46%
controls:0.41%
cases:2.61%
controls:1.36%
30
129
826
8421
9
39
847
8511
—
—
—
12
34
812
8275
19
99
708
7167
Cervical spine MRI examination with high intensity magnet
NA1BG [2001306990]
NA1BG [2001306990]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.61%
controls:0.32%
—
—
—
—
—
—
19
23
708
7243
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
50554-5 [3029287]
3.3e-01
3.2e-01
5.8e-01
1.0e+50
1.5e+00
6.0e-01
6.7e-01
cases:7.59%
controls:5.56%
cases:3.74%
controls:2.74%
cases:0.58%
controls:0.33%
cases:1.17%
controls:0.00%
cases:1.65%
controls:0.39%
cases:4.13%
controls:2.30%
cases:12.52%
controls:6.81%
65
475
791
8075
32
234
824
8316
5
28
851
8522
10
0
846
8550
14
33
836
8501
34
191
790
8118
91
495
636
6771
Status asthmaticus
J46 [45591560]
J46 [45591560]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.10%
controls:0.14%
—
—
—
—
—
—
8
10
719
7256
Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
11259-9 [3021125]
11259-9 [3021125]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.10%
controls:0.14%
—
—
—
—
—
—
8
10
719
7256
epinephrine; parenteral
C01CA24 [21600303]
C01CA24 [21600303]
1.0e+00
1.0e+00
—
—
—
1.0e+00
1.1e+00
cases:2.92%
controls:1.10%
cases:1.17%
controls:0.43%
—
—
—
—
—
—
cases:1.33%
controls:0.48%
cases:2.89%
controls:0.99%
25
94
831
8456
10
37
846
8513
—
—
—
11
40
813
8269
21
72
706
7194
epinephrine
S01EA01 [21603673]
S01EA01 [21603673]
1.0e+00
1.0e+00
—
—
—
1.0e+00
1.1e+00
cases:2.92%
controls:1.10%
cases:1.17%
controls:0.43%
—
—
—
—
—
—
cases:1.33%
controls:0.48%
cases:2.89%
controls:0.99%
25
94
831
8456
10
37
846
8513
—
—
—
11
40
813
8269
21
72
706
7194
Lumbar and other intervertebral disc disorders with radiculopathy
M51.1 [45562747]
M51.1 [45562747]
5.5e-01
7.9e-01
-1.0e+50
—
—
1.3e+00
8.2e-01
cases:2.34%
controls:1.36%
cases:0.82%
controls:0.37%
cases:0.00%
controls:0.06%
—
—
—
—
cases:1.46%
controls:0.42%
cases:3.71%
controls:1.67%
20
116
836
8434
7
32
849
8518
0
5
856
8545
—
—
12
35
812
8274
27
121
700
7145
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
30391-7 [3002582]
4.3e-01
4.8e-01
1.2e+00
1.0e+50
1.4e+00
5.3e-01
7.0e-01
cases:7.01%
controls:4.68%
cases:3.86%
controls:2.43%
cases:0.93%
controls:0.29%
cases:1.29%
controls:0.00%
cases:1.53%
controls:0.40%
cases:3.52%
controls:2.09%
cases:11.83%
controls:6.26%
60
400
796
8150
33
208
823
8342
8
25
848
8525
11
0
845
8550
13
34
837
8500
29
174
795
8135
86
455
641
6811
Ethanol [Moles/volume] in Serum or Plasma
14719-9 [3020191]
14719-9 [3020191]
—
—
—
1.0e+50
—
—
2.1e+00
—
—
—
—
—
—
cases:0.70%
controls:0.00%
—
—
—
—
cases:1.38%
controls:0.18%
—
—
—
6
0
850
8550
—
—
10
13
717
7253
Other and unspecified symptoms and signs involving cognitive functions and awareness
R41.8 [45534452]
R41.8 [45534452]
1.0e+00
1.3e+00
—
—
—
2.0e+00
-2.2e-01
cases:1.52%
controls:0.56%
cases:0.70%
controls:0.19%
—
—
—
—
—
—
cases:1.09%
controls:0.14%
cases:0.69%
controls:0.85%
13
48
843
8502
6
16
850
8534
—
—
—
9
12
815
8297
5
62
722
7204
Severe depressive episode with psychotic symptoms
F32.3 [45600739]
F32.3 [45600739]
9.6e-01
—
—
—
—
2.0e+00
—
cases:0.70%
controls:0.27%
—
—
—
—
—
—
—
—
cases:0.73%
controls:0.10%
—
—
6
23
850
8527
—
—
—
—
6
8
818
8301
—
mianserin; oral
N06AX03 [21604732]
N06AX03 [21604732]
1.4e+00
—
-1.0e+50
—
—
—
2.0e+00
cases:1.05%
controls:0.27%
—
—
cases:0.00%
controls:0.06%
—
—
—
—
—
—
cases:1.24%
controls:0.17%
9
23
847
8527
—
0
5
856
8545
—
—
—
9
12
718
7254
Other bipolar affective disorders
F31.8 [45586237]
F31.8 [45586237]
1.2e+00
2.0e+00
—
—
—
—
1.5e+00
cases:0.70%
controls:0.21%
cases:0.70%
controls:0.09%
—
—
—
—
—
—
—
—
cases:0.96%
controls:0.21%
6
18
850
8532
6
8
850
8542
—
—
—
—
7
15
720
7251
biperiden; oral, parenteral
N04AA02 [21604447]
N04AA02 [21604447]
2.0e+00
—
—
—
—
—
—
cases:0.70%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
—
—
6
8
850
8542
—
—
—
—
—
—
Migraine
N89 [2002000789]
N89 [2002000789]
5.1e-01
1.5e+00
—
—
—
2.0e+00
1.1e+00
cases:0.93%
controls:0.56%
cases:0.70%
controls:0.16%
—
—
—
—
—
—
cases:0.97%
controls:0.13%
cases:1.65%
controls:0.58%
8
48
848
8502
6
14
850
8536
—
—
—
8
11
816
8298
12
42
715
7224
2-person team, doctor-nurse
ZXY51 [2001311525]
ZXY51 [2001311525]
2.0e+00
—
—
—
—
—
—
cases:0.93%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
—
—
8
11
848
8539
—
—
—
—
—
—
Emotionally unstable personality disorder
F60.3 [45566852]
F60.3 [45566852]
2.0e+00
—
—
—
-1.0e+50
—
—
cases:0.93%
controls:0.13%
—
—
—
—
—
—
cases:0.00%
controls:0.06%
—
—
—
—
8
11
848
8539
—
—
—
0
5
850
8529
—
—
Other migraine
G43.8 [45595941]
G43.8 [45595941]
2.0e+00
—
—
—
—
—
—
cases:0.93%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
—
—
8
11
848
8539
—
—
—
—
—
—
Leukocytes [#/volume] in Urine
30405-5 [3018095]
30405-5 [3018095]
4.4e-01
5.0e-01
8.3e-01
1.0e+50
1.4e+00
5.4e-01
6.1e-01
cases:8.06%
controls:5.35%
cases:4.79%
controls:2.96%
cases:0.93%
controls:0.41%
cases:1.29%
controls:0.00%
cases:1.76%
controls:0.46%
cases:4.61%
controls:2.74%
cases:14.03%
controls:8.12%
69
457
787
8093
41
253
815
8297
8
35
848
8515
11
0
845
8550
15
39
835
8495
38
228
786
8081
102
590
625
6676
Ileoscopy through colon
UJF30 [2001305028]
UJF30 [2001305028]
9.7e-01
1.3e+00
—
—
—
7.9e-01
1.0e+00
cases:2.22%
controls:0.85%
cases:0.58%
controls:0.16%
—
—
—
—
—
—
cases:0.61%
controls:0.28%
cases:2.48%
controls:0.92%
19
73
837
8477
5
14
851
8536
—
—
—
5
23
819
8286
18
67
709
7199
Open wound of finger(s) without damage to nail
S61.0 [45578756]
S61.0 [45578756]
9.6e-01
—
—
—
—
1.1e+00
1.0e+00
cases:2.10%
controls:0.82%
—
—
—
—
—
—
—
—
cases:0.97%
controls:0.31%
cases:2.61%
controls:0.98%
18
70
838
8480
—
—
—
—
8
26
816
8283
19
71
708
7195
Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
70242-3 [42868716]
70242-3 [42868716]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.96%
controls:0.14%
—
—
—
—
—
—
7
10
720
7256
Vibrio sp identified in Specimen by Organism specific culture
6581-3 [3005988]
6581-3 [3005988]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.96%
controls:0.14%
—
—
—
—
—
—
7
10
720
7256
Contusion of eyelid and periocular area
S00.1 [45553759]
S00.1 [45553759]
2.1e+00
—
—
1.0e+50
—
—
2.0e+00
cases:0.58%
controls:0.07%
—
—
—
—
cases:1.75%
controls:0.00%
—
—
—
—
cases:0.96%
controls:0.14%
5
6
851
8544
—
—
15
0
841
8550
—
—
7
10
720
7256
Yersinia sp identified in Specimen by Organism specific culture
701-3 [3025468]
701-3 [3025468]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.96%
controls:0.14%
—
—
—
—
—
—
7
10
720
7256
Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
82198-3 [21493466]
82198-3 [21493466]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.96%
controls:0.14%
—
—
—
—
—
—
7
10
720
7256
Gastritis, unspecified
K29.7 [45591583]
K29.7 [45591583]
—
—
—
—
—
-1.0e+50
1.9e+00
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.06%
cases:1.24%
controls:0.18%
—
—
—
—
—
0
5
824
8304
9
13
718
7253
Other minor procedure on skin
TQW99 [2001310150]
TQW99 [2001310150]
—
—
—
—
—
—
1.9e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.24%
controls:0.18%
—
—
—
—
—
—
9
13
718
7253
Other childhood emotional disorders
F93.89 [2000502046]
F93.89 [2000502046]
1.9e+00
—
—
—
—
—
—
cases:1.05%
controls:0.15%
—
—
—
—
—
—
—
—
—
—
—
—
9
13
847
8537
—
—
—
—
—
—
diclofenac; oral, parenteral, rectal
M01AB05 [21603945]
M01AB05 [21603945]
5.1e-01
8.2e-01
5.8e-01
—
1.0e+00
4.8e-01
6.0e-01
cases:19.86%
controls:12.91%
cases:8.76%
controls:4.06%
cases:1.17%
controls:0.65%
—
—
cases:1.18%
controls:0.43%
cases:6.43%
controls:4.09%
cases:19.67%
controls:11.79%
170
1104
686
7446
75
347
781
8203
10
56
846
8494
—
10
37
840
8497
53
340
771
7969
143
857
584
6409
Medical doctor
Z2221 [2001311556]
Z2221 [2001311556]
3.3e-01
3.8e-01
—
1.0e+50
1.6e+00
8.7e-01
1.1e+00
cases:6.07%
controls:4.46%
cases:1.87%
controls:1.29%
—
—
cases:0.82%
controls:0.00%
cases:0.71%
controls:0.14%
cases:2.31%
controls:0.97%
cases:6.33%
controls:2.30%
52
381
804
8169
16
110
840
8440
—
7
0
849
8550
6
12
844
8522
19
81
805
8228
46
167
681
7099
Diarrhoea
D11 [2002000310]
D11 [2002000310]
9.0e-01
2.7e-01
-1.0e+50
—
-1.0e+50
6.1e-01
1.0e+00
cases:3.97%
controls:1.66%
cases:0.58%
controls:0.44%
cases:0.00%
controls:0.06%
—
—
cases:0.00%
controls:0.06%
cases:0.73%
controls:0.40%
cases:4.40%
controls:1.64%
34
142
822
8408
5
38
851
8512
0
5
856
8545
—
0
5
850
8529
6
33
818
8276
32
119
695
7147
Thorax X-ray examination
GD1AA [2001303617]
GD1AA [2001303617]
3.7e-01
6.1e-01
9.9e-01
1.0e+50
—
1.0e+00
9.0e-01
cases:7.36%
controls:5.20%
cases:3.86%
controls:2.13%
cases:0.82%
controls:0.30%
cases:2.10%
controls:0.00%
—
—
cases:4.25%
controls:1.60%
cases:11.69%
controls:5.11%
63
445
793
8105
33
182
823
8368
7
26
849
8524
18
0
838
8550
—
35
133
789
8176
85
371
642
6895
naproxen and esomeprazole; oral
M01AE52 [40254096]
M01AE52 [40254096]
8.5e-01
8.3e-01
—
—
—
6.4e-01
1.0e+00
cases:2.57%
controls:1.11%
cases:1.17%
controls:0.51%
—
—
—
—
—
—
cases:0.73%
controls:0.39%
cases:3.85%
controls:1.39%
22
95
834
8455
10
44
846
8506
—
—
—
6
32
818
8277
28
101
699
7165
Basophils/Leukocytes in Blood
30180-4 [3022096]
30180-4 [3022096]
4.4e-01
5.1e-01
9.2e-01
—
3.2e-01
3.6e-01
3.6e-01
cases:12.62%
controls:8.48%
cases:7.83%
controls:4.84%
cases:2.57%
controls:1.04%
—
—
cases:1.41%
controls:1.03%
cases:7.04%
controls:5.02%
cases:14.86%
controls:10.83%
108
725
748
7825
67
414
789
8136
22
89
834
8461
—
12
88
838
8446
58
417
766
7892
108
787
619
6479
Other and unspecified convulsions
R56.8 [45602033]
R56.8 [45602033]
8.0e-01
1.7e+00
—
—
—
1.9e+00
7.3e-01
cases:1.17%
controls:0.53%
cases:0.58%
controls:0.11%
—
—
—
—
—
—
cases:0.85%
controls:0.13%
cases:0.96%
controls:0.47%
10
45
846
8505
5
9
851
8541
—
—
—
7
11
817
8298
7
34
720
7232
Sprain and strain of finger(s)
S63.6 [45564454]
S63.6 [45564454]
1.1e+00
—
—
—
—
1.9e+00
7.2e-01
cases:1.17%
controls:0.37%
—
—
—
—
—
—
—
—
cases:0.85%
controls:0.13%
cases:1.24%
controls:0.61%
10
32
846
8518
—
—
—
—
7
11
817
8298
9
44
718
7222
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
26450-7 [3006504]
4.4e-01
5.0e-01
9.3e-01
—
3.3e-01
3.6e-01
3.7e-01
cases:12.62%
controls:8.54%
cases:7.71%
controls:4.83%
cases:2.57%
controls:1.03%
—
—
cases:1.41%
controls:1.02%
cases:7.04%
controls:4.99%
cases:14.99%
controls:10.90%
108
730
748
7820
66
413
790
8137
22
88
834
8462
—
12
87
838
8447
58
415
766
7894
109
792
618
6474
Haematemesis
K92.0 [45605964]
K92.0 [45605964]
—
-1.0e+50
—
—
—
—
1.9e+00
—
—
cases:0.00%
controls:0.06%
—
—
—
—
—
—
—
—
cases:0.96%
controls:0.15%
—
0
5
856
8545
—
—
—
—
7
11
720
7255
Campylobacter sp identified in Specimen by Organism specific culture
6332-1 [3012568]
6332-1 [3012568]
—
—
—
—
—
—
1.9e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.96%
controls:0.15%
—
—
—
—
—
—
7
11
720
7255
Salmonella sp identified in Specimen by Organism specific culture
17563-8 [3024522]
17563-8 [3024522]
—
—
—
—
—
—
1.9e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.96%
controls:0.15%
—
—
—
—
—
—
7
11
720
7255
Neurosurgery
14 [38004459]
14 [38004459]
2.9e-01
8.1e-01
—
1.0e+50
—
1.1e+00
7.7e-01
cases:2.34%
controls:1.77%
cases:1.52%
controls:0.68%
—
—
cases:0.70%
controls:0.00%
—
—
cases:2.18%
controls:0.75%
cases:3.44%
controls:1.62%
20
151
836
8399
13
58
843
8492
—
6
0
850
8550
—
18
62
806
8247
25
118
702
7148
zopiclone; oral
N05CF01 [21604654]
N05CF01 [21604654]
5.7e-01
6.7e-01
5.0e-01
—
1.7e-01
2.2e-01
6.2e-01
cases:8.18%
controls:4.78%
cases:4.67%
controls:2.46%
cases:1.05%
controls:0.64%
—
—
cases:0.71%
controls:0.60%
cases:3.16%
controls:2.55%
cases:9.08%
controls:5.11%
70
409
786
8141
40
210
816
8340
9
55
847
8495
—
6
51
844
8483
26
212
798
8097
66
371
661
6895
Sepsis, unspecified
A41.9 [45585911]
A41.9 [45585911]
1.9e+00
—
—
—
—
—
—
cases:0.82%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
—
—
7
11
849
8539
—
—
—
—
—
—
Contusion of thorax
S20.2 [45597402]
S20.2 [45597402]
1.0e+00
1.8e+00
—
1.0e+50
—
1.9e+00
1.8e+00
cases:1.05%
controls:0.39%
cases:0.58%
controls:0.09%
—
—
cases:1.52%
controls:0.00%
—
—
cases:0.73%
controls:0.11%
cases:2.48%
controls:0.40%
9
33
847
8517
5
8
851
8542
—
13
0
843
8550
—
6
9
818
8300
18
29
709
7237
Muscle strain
M62.6 [45587017]
M62.6 [45587017]
—
-1.0e+50
—
—
—
—
1.8e+00
—
—
cases:0.00%
controls:0.06%
—
—
—
—
—
—
—
—
cases:1.38%
controls:0.22%
—
0
5
856
8545
—
—
—
—
10
16
717
7250
Urinary tract infection, site not specified
N39.0 [45548665]
N39.0 [45548665]
9.1e-01
8.4e-01
—
—
—
1.1e+00
9.2e-01
cases:3.50%
controls:1.44%
cases:1.05%
controls:0.46%
—
—
—
—
—
—
cases:1.33%
controls:0.45%
cases:4.40%
controls:1.80%
30
123
826
8427
9
39
847
8511
—
—
—
11
37
813
8272
32
131
695
7135
bupropion; oral
N06AX12 [21604741]
N06AX12 [21604741]
9.0e-01
8.4e-01
—
—
—
4.4e-01
9.3e-01
cases:2.57%
controls:1.06%
cases:1.64%
controls:0.71%
—
—
—
—
—
—
cases:1.33%
controls:0.87%
cases:3.85%
controls:1.56%
22
91
834
8459
14
61
842
8489
—
—
—
11
72
813
8237
28
113
699
7153
Cardiac ultrasound examination through oesophagus
FM1BE [2001303285]
FM1BE [2001303285]
—
—
—
—
—
—
1.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.10%
controls:0.18%
—
—
—
—
—
—
8
13
719
7253
Basophils [#/volume] in Blood
26444-0 [3006315]
26444-0 [3006315]
4.1e-01
5.7e-01
8.4e-01
—
3.0e-01
3.1e-01
3.3e-01
cases:13.08%
controls:9.06%
cases:8.88%
controls:5.20%
cases:2.45%
controls:1.08%
—
—
cases:1.41%
controls:1.05%
cases:7.40%
controls:5.54%
cases:15.68%
controls:11.77%
112
775
744
7775
76
445
780
8105
21
92
835
8458
—
12
90
838
8444
61
460
763
7849
114
855
613
6411
Open wound of wrist and hand, part unspecified
S61.9 [45554740]
S61.9 [45554740]
1.8e+00
—
—
—
—
—
—
cases:1.29%
controls:0.21%
—
—
—
—
—
—
—
—
—
—
—
—
11
18
845
8532
—
—
—
—
—
—
Social worker
Z2446 [2001311559]
Z2446 [2001311559]
6.0e-01
8.2e-01
—
—
—
1.6e+00
1.8e+00
cases:1.64%
controls:0.90%
cases:0.58%
controls:0.26%
—
—
—
—
—
—
cases:0.61%
controls:0.12%
cases:2.48%
controls:0.41%
14
77
842
8473
5
22
851
8528
—
—
—
5
10
819
8299
18
30
709
7236
pH of Venous blood
2746-6 [3012544]
2746-6 [3012544]
3.6e-01
1.0e+00
—
—
—
6.8e-01
7.7e-01
cases:1.87%
controls:1.31%
cases:1.64%
controls:0.58%
—
—
—
—
—
—
cases:1.09%
controls:0.55%
cases:4.13%
controls:1.95%
16
112
840
8438
14
50
842
8500
—
—
—
9
46
815
8263
30
142
697
7124
Reaction to severe stress, unspecified
F43.9 [45552484]
F43.9 [45552484]
1.8e+00
—
—
—
—
1.8e+00
9.6e-01
cases:1.40%
controls:0.23%
—
—
—
—
—
—
—
—
cases:0.73%
controls:0.12%
cases:0.96%
controls:0.37%
12
20
844
8530
—
—
—
—
6
10
818
8299
7
27
720
7239
buspirone; oral
N05BE01 [21604601]
N05BE01 [21604601]
1.3e+00
—
—
—
—
1.3e+00
1.8e+00
cases:1.05%
controls:0.29%
—
—
—
—
—
—
—
—
cases:0.61%
controls:0.17%
cases:1.24%
controls:0.21%
9
25
847
8525
—
—
—
—
5
14
819
8295
9
15
718
7251
Lithium [Moles/volume] in Serum or Plasma
14334-7 [3024666]
14334-7 [3024666]
1.8e+00
1.5e+00
—
—
—
—
—
cases:1.05%
controls:0.18%
cases:0.58%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
9
15
847
8535
5
11
851
8539
—
—
—
—
—
Examination and observation for other specified reasons
Z04.8 [45552063]
Z04.8 [45552063]
8.6e-01
1.1e+00
—
—
—
6.6e-01
9.4e-01
cases:3.15%
controls:1.36%
cases:1.17%
controls:0.40%
—
—
—
—
—
—
cases:1.09%
controls:0.57%
cases:3.44%
controls:1.38%
27
116
829
8434
10
34
846
8516
—
—
—
9
47
815
8262
25
100
702
7166
pantoprazole; oral, parenteral
A02BC02 [21600097]
A02BC02 [21600097]
5.1e-01
3.6e-01
3.8e-01
—
7.1e-01
5.8e-01
7.0e-01
cases:17.87%
controls:11.58%
cases:8.41%
controls:6.02%
cases:1.87%
controls:1.29%
—
—
cases:2.59%
controls:1.29%
cases:10.68%
controls:6.26%
cases:24.76%
controls:14.00%
153
990
703
7560
72
515
784
8035
16
110
840
8440
—
22
110
828
8424
88
520
736
7789
180
1017
547
6249
Monocytes [#/volume] in Blood
26484-6 [3001604]
26484-6 [3001604]
4.0e-01
5.6e-01
8.3e-01
—
3.0e-01
3.1e-01
3.4e-01
cases:12.85%
controls:9.03%
cases:8.76%
controls:5.18%
cases:2.45%
controls:1.09%
—
—
cases:1.41%
controls:1.05%
cases:7.40%
controls:5.56%
cases:15.68%
controls:11.70%
110
772
746
7778
75
443
781
8107
21
93
835
8457
—
12
90
838
8444
61
462
763
7847
114
850
613
6416
CT of paranasal sinuses and face area
DM1AD [2001301741]
DM1AD [2001301741]
1.1e+00
-1.0e+50
—
1.0e+50
—
—
1.8e+00
cases:0.70%
controls:0.25%
cases:0.00%
controls:0.06%
—
—
cases:1.05%
controls:0.00%
—
—
—
—
cases:1.38%
controls:0.23%
6
21
850
8529
0
5
856
8545
—
9
0
847
8550
—
—
10
17
717
7249
Haemorrhage of anus and rectum
K62.5 [45596339]
K62.5 [45596339]
—
—
—
—
—
1.8e+00
5.1e-01
—
—
—
—
—
—
—
—
—
—
cases:0.85%
controls:0.14%
cases:0.83%
controls:0.50%
—
—
—
—
—
7
12
817
8297
6
36
721
7230
Weight gain
T07 [2002001070]
T07 [2002001070]
—
-1.0e+50
—
—
—
—
1.8e+00
—
—
cases:0.00%
controls:0.07%
—
—
—
—
—
—
—
—
cases:0.96%
controls:0.17%
—
0
6
856
8544
—
—
—
—
7
12
720
7254
Alcohol depence active use
F10.24 [2000501681]
F10.24 [2000501681]
—
—
—
—
—
—
1.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.96%
controls:0.17%
—
—
—
—
—
—
7
12
720
7254
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
26511-6 [3018010]
4.6e-01
4.0e-01
9.3e-01
—
2.8e-01
3.2e-01
3.8e-01
cases:12.85%
controls:8.55%
cases:7.13%
controls:4.88%
cases:2.45%
controls:0.98%
—
—
cases:1.29%
controls:0.98%
cases:6.80%
controls:5.03%
cases:15.41%
controls:11.04%
110
731
746
7819
61
417
795
8133
21
84
835
8466
—
11
84
839
8450
56
418
768
7891
112
802
615
6464
omeprazole; oral, parenteral
A02BC01 [21600096]
A02BC01 [21600096]
3.0e-01
6.8e-01
—
—
9.2e-01
9.9e-01
7.8e-01
cases:3.86%
controls:2.88%
cases:1.99%
controls:1.02%
—
—
—
—
cases:0.59%
controls:0.23%
cases:2.67%
controls:1.01%
cases:4.95%
controls:2.34%
33
246
823
8304
17
87
839
8463
—
—
5
20
845
8514
22
84
802
8225
36
170
691
7096
Procedure duration 10 to 19 minutes
ZXE02 [2001311396]
ZXE02 [2001311396]
3.3e-02
—
—
—
—
—
1.8e+00
cases:0.70%
controls:0.68%
—
—
—
—
—
—
—
—
—
—
cases:1.65%
controls:0.29%
6
58
850
8492
—
—
—
—
—
12
21
715
7245
Intensive care
WX872 [2001310844]
WX872 [2001310844]
—
—
—
—
—
—
1.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.10%
controls:0.19%
—
—
—
—
—
—
8
14
719
7252
Psychologist
Z2445 [2001311558]
Z2445 [2001311558]
6.3e-01
-1.0e+50
-1.0e+50
—
—
—
1.7e+00
cases:1.40%
controls:0.75%
cases:0.00%
controls:0.32%
cases:0.00%
controls:0.07%
—
—
—
—
—
—
cases:1.24%
controls:0.22%
12
64
844
8486
0
27
856
8523
0
6
856
8544
—
—
—
9
16
718
7250
Acute inflammatory disease of uterus
N71.0 [45596880]
N71.0 [45596880]
1.3e+00
—
—
—
—
—
1.7e+00
cases:0.93%
controls:0.26%
—
—
—
—
—
—
—
—
—
—
cases:1.24%
controls:0.22%
8
22
848
8528
—
—
—
—
—
9
16
718
7250
nitrofurantoin; oral
J01XE01 [21603058]
J01XE01 [21603058]
7.9e-01
9.4e-01
—
—
—
7.1e-01
6.1e-01
cases:4.44%
controls:2.06%
cases:1.99%
controls:0.78%
—
—
—
—
—
—
cases:1.82%
controls:0.90%
cases:4.40%
controls:2.44%
38
176
818
8374
17
67
839
8483
—
—
—
15
75
809
8234
32
177
695
7089
venlafaxine; oral
N06AX16 [21604745]
N06AX16 [21604745]
8.4e-01
8.9e-01
—
—
7.9e-01
7.2e-01
5.4e-01
cases:5.02%
controls:2.23%
cases:3.39%
controls:1.42%
—
—
—
—
cases:0.82%
controls:0.37%
cases:2.67%
controls:1.31%
cases:4.26%
controls:2.52%
43
191
813
8359
29
121
827
8429
—
—
7
32
843
8502
22
109
802
8200
31
183
696
7083
duloxetine; oral
N06AX21 [21604749]
N06AX21 [21604749]
9.0e-01
8.8e-01
1.1e+00
—
1.4e+00
9.7e-01
8.0e-01
cases:2.69%
controls:1.11%
cases:1.75%
controls:0.74%
cases:0.82%
controls:0.28%
—
—
cases:1.06%
controls:0.26%
cases:1.82%
controls:0.70%
cases:3.58%
controls:1.64%
23
95
833
8455
15
63
841
8487
7
24
849
8526
—
9
22
841
8512
15
58
809
8251
26
119
701
7147
Mixed anxiety and depressive disorder
F41.2 [45566845]
F41.2 [45566845]
9.5e-01
7.8e-01
—
—
—
8.9e-01
7.5e-01
cases:3.50%
controls:1.39%
cases:1.75%
controls:0.81%
—
—
—
—
—
—
cases:1.82%
controls:0.76%
cases:4.68%
controls:2.26%
30
119
826
8431
15
69
841
8481
—
—
—
15
63
809
8246
34
164
693
7102
Monitored bed care
WX892 [2001310850]
WX892 [2001310850]
5.8e-01
—
-1.0e+50
—
—
—
1.7e+00
cases:1.17%
controls:0.65%
—
—
cases:0.00%
controls:0.06%
—
—
—
—
—
—
cases:2.06%
controls:0.39%
10
56
846
8494
—
0
5
856
8545
—
—
—
15
28
712
7238
Hand Surgery
40 [38004480]
40 [38004480]
8.3e-01
9.1e-01
-1.0e+50
—
—
8.5e-01
8.6e-01
cases:4.44%
controls:1.98%
cases:1.87%
controls:0.76%
cases:0.00%
controls:0.11%
—
—
—
—
cases:1.46%
controls:0.63%
cases:5.78%
controls:2.53%
38
169
818
8381
16
65
840
8485
0
9
856
8541
—
—
12
52
812
8257
42
184
685
7082
Therapeutic discussion
SPAT1240 [2001700341]
SPAT1240 [2001700341]
7.8e-01
2.1e-01
—
—
—
7.5e-01
9.0e-01
cases:4.32%
controls:2.02%
cases:0.93%
controls:0.76%
—
—
—
—
—
—
cases:1.82%
controls:0.87%
cases:5.09%
controls:2.13%
37
173
819
8377
8
65
848
8485
—
—
—
15
72
809
8237
37
155
690
7111
olanzapine and samidorphan
N05AH53 [955100]
N05AH53 [955100]
1.7e+00
—
—
—
—
—
1.3e+00
cases:0.93%
controls:0.18%
—
—
—
—
—
—
—
—
—
—
cases:0.69%
controls:0.19%
8
15
848
8535
—
—
—
—
—
5
14
722
7252
Fracture of lateral malleolus
S82.6 [45569819]
S82.6 [45569819]
1.0e+00
-1.0e+50
—
—
—
—
1.7e+00
cases:0.58%
controls:0.21%
cases:0.00%
controls:0.08%
—
—
—
—
—
—
—
—
cases:1.24%
controls:0.23%
5
18
851
8532
0
7
856
8543
—
—
—
—
9
17
718
7249
Bipolar disorder Depressive episode without somatic syndrome
F31.30 [2000501976]
F31.30 [2000501976]
1.4e+00
—
—
—
—
—
1.7e+00
cases:0.82%
controls:0.21%
—
—
—
—
—
—
—
—
—
—
cases:1.24%
controls:0.23%
7
18
849
8532
—
—
—
—
—
9
17
718
7249
Hepatitis A virus Ab [Presence] in Serum
20575-7 [3016650]
20575-7 [3016650]
1.2e+00
—
—
—
—
—
1.7e+00
cases:0.93%
controls:0.28%
—
—
—
—
—
—
—
—
—
—
cases:1.24%
controls:0.23%
8
24
848
8526
—
—
—
—
—
9
17
718
7249
Fractional oxyhemoglobin in Venous blood
2716-9 [3019230]
2716-9 [3019230]
-1.0e+50
—
—
—
—
—
1.7e+00
cases:0.00%
controls:0.15%
—
—
—
—
—
—
—
—
—
—
cases:1.38%
controls:0.26%
0
13
856
8537
—
—
—
—
—
10
19
717
7247
Ammonium ion [Moles/volume] in Plasma
1845-7 [3023183]
1845-7 [3023183]
—
—
—
—
—
—
1.7e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.38%
controls:0.26%
—
—
—
—
—
—
10
19
717
7247
orphenadrine, combinations
M03BC51 [21604113]
M03BC51 [21604113]
5.9e-01
7.4e-01
1.6e+00
—
—
1.1e+00
4.8e-01
cases:5.02%
controls:2.84%
cases:1.87%
controls:0.90%
cases:0.58%
controls:0.12%
—
—
—
—
cases:2.06%
controls:0.72%
cases:4.81%
controls:3.04%
43
243
813
8307
16
77
840
8473
5
10
851
8540
—
—
17
60
807
8249
35
221
692
7045
Throat symptom/complaint
R21 [2002000891]
R21 [2002000891]
7.2e-01
4.5e-01
1.4e+00
—
—
9.3e-01
4.7e-01
cases:8.41%
controls:4.29%
cases:2.22%
controls:1.43%
cases:0.58%
controls:0.14%
—
—
—
—
cases:3.03%
controls:1.22%
cases:6.88%
controls:4.43%
72
367
784
8183
19
122
837
8428
5
12
851
8538
—
—
25
101
799
8208
50
322
677
6944
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
751-8 [3013650]
3.5e-01
4.4e-01
6.0e-01
—
3.2e-01
4.4e-01
4.2e-01
cases:14.49%
controls:10.65%
cases:9.46%
controls:6.30%
cases:2.80%
controls:1.56%
—
—
cases:2.12%
controls:1.55%
cases:9.47%
controls:6.32%
cases:18.84%
controls:13.28%
124
911
732
7639
81
539
775
8011
24
133
832
8417
—
18
132
832
8402
78
525
746
7784
137
965
590
6301
metoclopramide; oral, parenteral, rectal
A03FA01 [21600484]
A03FA01 [21600484]
7.2e-01
6.6e-01
—
—
—
9.3e-01
5.1e-01
cases:6.54%
controls:3.31%
cases:1.64%
controls:0.85%
—
—
—
—
—
—
cases:2.43%
controls:0.97%
cases:5.09%
controls:3.11%
56
283
800
8267
14
73
842
8477
—
—
—
20
81
804
8228
37
226
690
7040
Chest pain, unspecified
R07.4 [45558450]
R07.4 [45558450]
6.0e-01
9.0e-01
—
—
—
8.8e-01
1.0e+00
cases:4.79%
controls:2.68%
cases:1.87%
controls:0.77%
—
—
—
—
—
—
cases:1.94%
controls:0.82%
cases:7.84%
controls:2.99%
41
229
815
8321
16
66
840
8484
—
—
—
16
68
808
8241
57
217
670
7049
Severe psychotic and other severe mental disorders
112 [2001600112]
112 [2001600112]
1.0e+00
—
—
—
—
—
1.6e+00
cases:1.52%
controls:0.56%
—
—
—
—
—
—
—
—
—
—
cases:1.38%
controls:0.28%
13
48
843
8502
—
—
—
—
—
10
20
717
7246
Fall on and from stairs and steps
W10 [45756250]
W10 [45756250]
9.9e-01
—
—
1.0e+50
—
1.7e+00
1.6e+00
cases:0.93%
controls:0.35%
—
—
—
—
cases:1.29%
controls:0.00%
—
—
cases:0.61%
controls:0.11%
cases:1.24%
controls:0.25%
8
30
848
8520
—
—
11
0
845
8550
—
5
9
819
8300
9
18
718
7248
Chronic periodontitis
K05.3 [45586694]
K05.3 [45586694]
—
—
—
—
—
—
1.6e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.24%
controls:0.25%
—
—
—
—
—
—
9
18
718
7248
Contusion of finger(s) without damage to nail
S60.0 [45535417]
S60.0 [45535417]
1.6e+00
—
—
—
—
—
—
cases:1.29%
controls:0.26%
—
—
—
—
—
—
—
—
—
—
—
—
11
22
845
8528
—
—
—
—
—
—
Social problem NOS
Z29 [2002001483]
Z29 [2002001483]
1.6e+00
—
—
—
—
2.3e+00
—
cases:0.93%
controls:0.19%
—
—
—
—
—
—
—
—
cases:0.61%
controls:0.06%
—
—
8
16
848
8534
—
—
—
—
5
5
819
8304
—
salmeterol and fluticasone
R03AK06 [21603280]
R03AK06 [21603280]
8.0e-01
6.6e-01
—
—
7.9e-01
7.0e-01
8.2e-01
cases:3.86%
controls:1.78%
cases:2.45%
controls:1.29%
—
—
—
—
cases:0.82%
controls:0.37%
cases:2.43%
controls:1.22%
cases:4.26%
controls:1.93%
33
152
823
8398
21
110
835
8440
—
—
7
32
843
8502
20
101
804
8208
31
140
696
7126
Audiology
64 [38004489]
64 [38004489]
1.9e-01
5.7e-01
—
—
1.6e+00
1.6e+00
5.1e-01
cases:2.10%
controls:1.74%
cases:1.52%
controls:0.87%
—
—
—
—
cases:0.59%
controls:0.12%
cases:3.03%
controls:0.63%
cases:2.75%
controls:1.67%
18
149
838
8401
13
74
843
8476
—
—
5
10
845
8524
25
52
799
8257
20
121
707
7145
varenicline; oral
N07BA03 [21604819]
N07BA03 [21604819]
5.8e-01
2.1e+00
—
—
—
2.0e+00
1.6e+00
cases:1.29%
controls:0.73%
cases:0.58%
controls:0.07%
—
—
—
—
—
—
cases:0.61%
controls:0.08%
cases:2.34%
controls:0.48%
11
62
845
8488
5
6
851
8544
—
—
—
5
7
819
8302
17
35
710
7231
INR in Blood by Coagulation assay
34714-6 [3032080]
34714-6 [3032080]
3.6e-01
4.5e-01
8.3e-01
—
4.0e-01
7.6e-01
8.1e-01
cases:8.64%
controls:6.21%
cases:4.79%
controls:3.11%
cases:2.10%
controls:0.92%
—
—
cases:1.41%
controls:0.95%
cases:6.31%
controls:3.06%
cases:14.58%
controls:7.03%
74
531
782
8019
41
266
815
8284
18
79
838
8471
—
12
81
838
8453
52
254
772
8055
106
511
621
6755
Oxygen saturation in Venous blood
2711-0 [3024928]
2711-0 [3024928]
—
—
—
—
—
—
1.6e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.38%
controls:0.29%
—
—
—
—
—
—
10
21
717
7245
Trochanteric bursitis
M70.6 [45606304]
M70.6 [45606304]
7.8e-01
1.6e+00
—
—
—
1.1e+00
8.3e-01
cases:1.87%
controls:0.87%
cases:1.17%
controls:0.25%
—
—
—
—
—
—
cases:0.85%
controls:0.29%
cases:2.34%
controls:1.03%
16
74
840
8476
10
21
846
8529
—
—
—
7
24
817
8285
17
75
710
7191
LabWAS
↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
343
2058
2.11
23.76
3.2
2.6
52.71
62.07
u/l
2.02
317
1937
399
2590
2.01
21.77
9.7
10.0
1.11
1.16
inr
1.81
337
2160
305
1812
2.06
21.17
2.8
2.1
187.90
278.36
u/l
0.80
297
1718
480
3389
1.95
19.86
5.9
6.4
9.87
11.08
umol/l
3.46
452
3238
222
1201
2.14
19.53
2.6
1.9
1.55
1.42
%
1.91
208
1096
532
3901
1.96
19.52
5.7
5.0
6.25
6.46
mmol/l
2.02
505
3621
323
2044
1.93
18.12
3.4
3.1
38.99
79.13
e6/l
0.50
243
1519
646
5147
2.03
17.64
8.2
7.6
74.05
76.16
u/l
0.79
619
4900
280
1757
1.88
15.65
3.1
3.0
0.16
0.26
e6/l
1.08
197
1244
384
2663
1.80
15.46
5.6
6.6
1.21
1.21
mmol/l
0.32
356
2479
364
2508
1.78
14.80
4.2
3.7
107.19
79.54
e6/l
0.16
259
1660
179
995
2.01
14.16
3.0
2.8
4.01
3.16
e6/l
0.35
88
471
416
3007
1.74
14.10
6.4
7.2
1.21
1.21
mmol/l
0.29
368
2631
333
2268
1.77
13.86
4.0
3.1
27.29
64.93
ng/l
0.61
192
1285
101
454
2.39
13.58
2.0
1.7
0.43
0.31
mg/l
0.89
48
217
31
69
4.62
13.15
2.0
1.5
1.77
1.38
promille
0.71
21
60
629
5169
1.81
13.06
4.6
4.0
9.57
9.38
mm/h
0.14
595
4898
528
4138
1.72
12.86
9.3
9.8
4.34
3.97
e9/l
2.79
464
3609
567
4546
1.73
12.56
5.5
4.0
2664.22
394.43
e6/l
—
9
65
168
962
1.93
12.04
2.1
1.8
—
—
—
0
0
257
1684
1.75
11.88
4.7
3.9
91.80
92.97
%
0.36
249
1648
38
107
3.67
11.84
6.2
7.0
334.52
379.59
umol/l
1.05
31
98
179
1060
1.87
11.54
2.9
2.7
0.86
0.99
e6/l
0.23
89
531
371
2706
1.65
11.39
4.3
5.2
36.63
36.97
g/l
0.57
350
2557
117
618
2.03
10.50
3.1
2.4
10208.88
5894.03
u/l
0.42
37
266
124
675
1.98
10.22
2.5
2.4
31.77
108.93
u/l
0.54
100
561
481
3808
1.60
10.14
3.9
3.4
0.00
0.00
estimate
0.50
101
808
798
7273
2.39
10.06
19.4
12.7
21.80
21.81
mg/l
0.00
679
5834
212
1382
1.71
9.71
2.7
2.6
7.61
6.99
e6/l
0.19
193
1242
243
1652
1.66
9.46
2.2
1.9
1.04
1.08
mg/l
0.07
178
1234
483
3865
1.57
9.43
4.0
3.4
0.00
0.39
estimate
0.50
101
760
123
686
1.93
9.42
2.0
1.7
—
—
—
0
0
363
2724
1.58
9.38
2.2
1.9
94.56
96.56
pmol/l
0.35
208
1528
637
5448
1.66
9.34
4.3
3.2
43.46
39.32
u/l
0.76
614
5237
481
3853
1.57
9.29
3.9
3.4
0.00
3.59
estimate
0.80
99
813
778
7058
2.10
9.28
19.4
13.6
139.49
139.60
mmol/l
0.75
770
6912
778
7071
2.08
9.03
19.4
13.7
3.94
3.94
mmol/l
0.03
768
6914
67
301
2.33
9.01
1.8
1.6
—
—
—
0
0
178
1149
1.69
8.33
4.9
3.6
176.99
713.74
ng/l
2.58
116
758
251
1769
1.59
8.27
2.2
2.2
2.79
2.68
mg/l
0.23
218
1554
20
31
6.58
8.22
5.0
5.7
193.11
175.28
umol/l
—
9
18
104
574
1.92
8.19
2.7
4.5
1.76
1.48
mmol/l
0.30
91
495
340
2572
1.53
8.17
3.6
3.5
29.20
31.65
u/l
0.83
320
2449
140
855
1.76
7.97
1.6
1.7
1093.36
1170.31
nmol/l
0.44
110
664
414
3291
1.50
7.73
2.8
2.8
—
—
estimate
—
0
0
747
6776
1.79
7.60
16.4
11.3
92.76
91.62
ml/min/173m2
0.77
688
6106
115
674
1.82
7.50
2.0
1.8
—
—
—
0
0
651
5744
1.55
6.93
5.1
4.3
14.53
14.50
pmol/l
0.13
607
5341
392
3129
1.47
6.91
2.6
2.5
70.57
73.03
nmol/l
0.98
369
2935
80
428
1.96
6.90
1.4
1.6
—
—
—
0
0
376
2978
1.47
6.89
3.8
3.2
0.03
0.02
estimate
0.12
76
679
238
1722
1.53
6.78
1.7
1.6
18.19
20.11
nmol/l
1.28
208
1508
124
765
1.73
6.78
6.9
7.5
104.97
104.58
mmol/l
0.47
124
765
174
1173
1.61
6.76
2.7
2.7
89.67
117.37
ug/g
0.96
133
951
229
1652
1.53
6.59
2.4
2.2
—
—
—
0
0
287
2175
1.48
6.49
1.9
1.7
—
—
—
0
0
240
1762
1.50
6.32
4.0
3.3
1.02
1.02
kg/l
0.23
148
1141
252
1878
1.48
6.14
3.3
2.3
—
—
—
0
0
53
260
2.11
5.82
3.4
4.1
47.86
49.68
%
0.21
53
254
70
381
1.91
5.76
2.7
2.3
14.39
7.97
ug/l
0.27
61
348
233
1730
1.48
5.73
3.2
2.2
—
—
—
0
0
124
800
1.64
5.71
2.7
3.3
5.37
7.68
umol/l
1.61
105
693
30
115
2.67
5.69
1.3
1.3
—
—
—
0
0
30
115
2.67
5.69
1.3
1.3
—
—
—
0
0
280
2157
1.44
5.67
3.1
3.2
2.35
2.35
mmol/l
0.23
261
2020
58
298
2.01
5.64
1.8
3.1
0.61
0.64
%
0.31
58
298
98
598
1.72
5.56
8.0
9.6
1.36
0.73
mmol/l
1.04
80
483
196
1413
1.50
5.56
1.4
1.3
16.22
24.08
iu/ml
1.68
58
415
21
68
3.14
5.37
1.9
1.7
—
—
—
0
0
226
1687
1.46
5.36
2.3
2.6
332.10
335.17
umol/l
0.18
199
1538
181
1295
1.50
5.30
1.4
1.3
2.73
7.50
u/ml
1.65
71
526
88
530
1.74
5.24
2.4
2.3
14.26
15.12
au/ml
0.07
13
73
263
2048
1.41
4.89
4.1
3.4
0.00
0.01
estimate
1.23
98
778
644
5816
1.43
4.83
4.2
3.6
—
—
—
0
0
236
1811
1.42
4.75
1.4
1.5
2.20
2.22
g/l
0.11
150
1169
142
995
1.51
4.56
2.0
2.4
2.46
2.38
g/l
0.97
135
918
804
7648
1.81
4.41
21.3
15.0
72.49
73.79
umol/l
1.14
799
7567
94
605
1.62
4.38
8.4
9.5
5.26
5.06
kpa
1.52
94
577
726
6744
1.50
4.37
6.3
5.1
1.71
1.80
mu/l
1.59
693
6404
35
165
2.17
4.30
1.2
1.3
—
—
—
0
0
42
213
2.02
4.28
2.0
1.8
—
—
—
0
0
82
516
1.65
4.18
8.8
10.1
121.67
124.54
g/l
0.62
82
504
149
1074
1.47
4.16
2.0
2.5
14.61
14.31
umol/l
0.18
140
999
800
7617
1.74
4.12
12.4
10.2
26.63
27.43
u/l
0.67
787
7454
88
567
1.62
4.09
2.3
2.6
0.23
0.23
g/l
0.02
79
528
44
232
1.95
4.04
2.0
1.9
—
—
—
0
0
9
14
6.48
3.99
1.3
1.4
1.17
1.19
mmol/l
—
9
14
710
6611
1.43
3.79
4.7
4.1
5.73
5.76
mmol/l
0.17
673
6225
260
2095
1.35
3.77
1.4
1.3
1.78
1.48
u/ml
0.18
75
575
140
1022
1.44
3.65
3.8
4.1
0.82
0.82
mmol/l
0.03
135
982
33
163
2.07
3.64
1.6
1.6
—
—
—
0
0
125
895
1.46
3.61
2.1
2.5
23.79
24.11
%
0.09
117
840
150
1113
1.42
3.58
2.9
2.6
2.44
2.43
mmol/l
0.68
136
999
68
426
1.65
3.55
4.6
3.6
5.33
5.09
kpa
1.38
61
410
34
172
2.02
3.53
1.4
2.6
0.86
0.79
g/l
0.04
29
156
33
166
2.03
3.48
1.2
1.6
3.64
12.55
e6/l
1.21
22
126
57
344
1.70
3.43
2.2
3.1
181.65
165.29
ng/l
0.12
49
303
38
203
1.91
3.40
1.4
1.3
—
—
—
0
0
179
1381
1.37
3.39
3.3
3.3
1418.47
996.39
ng/l
0.46
145
1134
163
1242
1.39
3.33
1.7
1.6
47518121.42
30939651.69
pmol/l
0.13
141
1086
18
71
2.57
3.31
19.4
12.9
0.57
0.61
mmol/l
0.31
18
64
113
811
1.45
3.23
4.1
7.0
1.01
1.05
mmol/l
1.02
107
762
447
3942
1.28
3.19
3.6
3.2
88.31
97.95
ug/l
0.74
429
3765
73
479
1.57
3.18
2.6
2.4
77.41
74.62
ml/min/173m2
0.23
32
215
276
2296
1.30
3.10
3.6
2.8
0.00
0.05
estimate
0.75
77
665
29
146
2.02
3.08
1.0
1.2
—
—
—
0
0
58
363
1.64
3.07
3.5
3.7
1.98
1.62
mmol/l
0.29
42
255
264
2188
1.30
3.04
4.6
3.6
8.47
8.46
mmol/l
0.01
240
1923
19
81
2.38
3.00
1.4
1.3
—
—
—
0
0
686
6422
1.34
2.96
5.5
5.1
37.40
37.85
mmol/mol
0.80
650
6145
13
46
2.85
2.93
2.5
2.2
—
—
—
0
0
32
171
1.91
2.89
1.3
1.6
119.35
765.69
e6/l
0.49
26
136
62
402
1.58
2.86
1.5
3.4
66.97
67.26
g/l
0.14
54
376
84
586
1.48
2.79
3.9
2.8
—
—
—
0
0
29
154
1.91
2.68
1.0
1.0
2.81
2.41
eliau/ml
0.10
15
73
42
251
1.71
2.67
1.0
1.1
1.07
3.92
eliau/ml
—
7
42
18
80
2.28
2.62
1.4
1.3
—
—
—
0
0
18
81
2.25
2.55
1.4
1.3
—
—
—
0
0
17
76
2.26
2.45
1.4
1.3
—
—
—
0
0
6
12
5.03
2.40
1.5
1.3
—
—
—
0
0
17
77
2.23
2.38
1.4
1.3
—
—
—
0
0
17
77
2.23
2.38
1.4
1.3
—
—
—
0
0
23
120
1.94
2.27
1.4
1.4
—
—
—
0
0
48
314
1.56
2.19
6.3
8.1
24.66
24.27
mmol/l
0.30
48
299
8
24
3.35
2.18
1.3
1.1
78.88
91.50
%
—
8
24
828
8084
1.69
2.16
27.8
19.3
261.75
255.57
e9/l
2.00
823
7962
35
212
1.68
2.16
1.2
1.1
—
—
—
0
0
30
174
1.75
2.16
1.3
1.6
—
—
—
0
0
30
174
1.75
2.16
1.2
1.6
152.91
138.14
au/ml
0.35
11
47
35
213
1.67
2.13
1.2
1.1
—
—
—
0
0
828
8091
1.67
2.06
27.8
19.3
4.56
4.60
e12/l
1.54
822
7962
13
56
2.34
2.05
3.8
1.9
17.40
18.22
mg/l
—
5
29
122
959
1.32
2.05
3.0
2.1
—
—
—
0
0
23
125
1.86
2.04
3.9
3.1
1.43
1.42
mmol/l
0.03
23
120
71
512
1.42
2.03
1.1
1.1
—
—
—
0
0
14
63
2.24
2.01
1.2
1.0
—
—
—
0
0
22
119
1.87
1.98
3.9
1.9
—
—
—
0
0
13
57
2.30
1.98
1.1
1.1
0.98
1.07
u/l
—
5
28
7
22
3.20
1.88
3.4
3.6
5.26
4.64
kpa
—
7
22
7
22
3.20
1.88
3.4
3.6
9.50
11.08
kpa
—
7
22
13
59
2.22
1.85
2.8
2.5
4.02
4.00
mmol/l
0.06
13
59
13
59
2.22
1.85
2.8
2.5
105.92
105.93
mmol/l
0.00
13
59
88
670
1.35
1.84
1.4
1.3
64.36
146.37
u/ml
2.94
31
278
5
12
4.18
1.82
1.2
1.2
—
—
—
0
0
40
264
1.54
1.79
1.3
1.3
—
—
—
0
0
8
29
2.77
1.79
1.1
1.6
—
—
—
0
0
8
29
2.77
1.79
1.1
1.6
—
—
—
0
0
8
29
2.77
1.79
1.1
1.6
—
—
—
0
0
8
29
2.77
1.79
1.1
1.6
—
—
—
0
0
20
109
1.85
1.78
1.1
1.3
—
—
—
0
0
18
96
1.89
1.71
1.4
1.5
—
—
—
0
0
45
309
1.48
1.69
11.9
12.8
15.92
16.32
%
0.40
45
295
44
304
1.47
1.62
2.2
1.8
—
—
—
0
0
169
1426
1.23
1.61
1.7
1.6
—
—
—
0
0
8
32
2.51
1.60
2.3
1.8
15.25
14.48
umol/l
—
8
32
19
106
1.81
1.60
1.8
1.7
—
—
—
0
0
25
152
1.66
1.58
2.8
3.0
1.18
2.09
index
0.41
11
83
94
743
1.30
1.55
2.3
2.1
363.44
380.02
nmol/l
0.40
86
696
733
7072
1.25
1.53
4.8
4.7
2.76
2.79
mmol/l
0.31
702
6753
5
15
3.35
1.52
1.0
1.2
—
—
—
0
0
137
1138
1.24
1.51
3.1
2.2
—
—
—
0
0
15
79
1.91
1.50
1.1
1.4
—
—
—
0
0
80
622
1.32
1.49
5.6
5.7
—
—
—
0
0
88
694
1.30
1.48
3.8
3.9
31.06
31.10
%
0.01
68
504
26
163
1.61
1.48
2.2
2.8
—
—
—
0
0
9
38
2.38
1.46
1.1
1.2
—
—
—
0
0
28
180
1.57
1.44
1.7
1.6
—
—
—
0
0
6
22
2.74
1.43
1.2
1.7
—
—
—
0
0
6
22
2.74
1.43
1.2
1.7
—
—
—
0
0
22
133
1.67
1.43
1.5
1.5
—
—
—
0
0
16
88
1.83
1.42
1.1
1.4
0.66
0.54
nmol/l
0.72
16
82
32
215
1.51
1.37
1.2
1.4
235.32
231.30
u/ml
0.03
25
128
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
41
2.21
1.37
1.1
1.2
—
—
—
0
0
6
23
2.62
1.37
1.2
1.7
—
—
—
0
0
6
23
2.62
1.37
1.0
1.3
—
—
—
0
0
12
61
1.98
1.33
1.8
2.0
0.39
1.15
u/ml
—
5
20
23
144
1.61
1.33
1.5
5.1
—
2063.50
u/ml
—
0
14
6
24
2.51
1.30
1.0
1.1
—
—
—
0
0
31
447
0.68
1.29
1.0
1.1
1.55
1.51
g/l
0.45
31
447
5
18
2.79
1.28
1.0
1.1
—
—
—
0
0
28
186
1.52
1.28
1.2
1.4
311.33
298.97
ug/g
0.12
15
99
24
154
1.57
1.27
1.5
1.4
—
—
—
0
0
9
45
2.01
1.23
1.7
3.3
1285.44
1475.02
mg
—
9
45
12
63
1.92
1.23
1.2
1.1
—
—
—
0
0
47
349
1.37
1.22
1.6
1.4
—
—
—
0
0
65
511
1.29
1.16
1.7
1.7
270.80
303.28
mu/l
0.46
57
465
0
34
0.00
1.16
0.0
1.2
—
72.71
—
0
34
20
126
1.60
1.15
1.8
2.4
83.62
125.29
ug/min
0.20
11
76
22
142
1.56
1.15
1.4
1.3
—
—
—
0
0
722
7002
1.20
1.14
4.3
4.2
1.40
1.43
mmol/l
1.20
691
6680
12
65
1.86
1.14
1.1
1.3
0.17
2.73
u/ml
—
7
36
55
424
1.32
1.13
2.4
3.9
1.23
1.23
mmol/l
0.38
42
366
95
785
1.24
1.13
2.9
2.4
11.74
13.48
nmol/l
1.51
89
736
724
7025
1.20
1.12
4.4
4.3
4.63
4.66
mmol/l
0.43
697
6728
8
40
2.01
1.12
1.3
1.6
—
—
—
0
0
33
235
1.42
1.10
5.0
6.7
2.02
1.61
%
0.81
33
219
23
152
1.53
1.10
2.7
1.5
377.12
355.56
mu/l
0.20
17
121
23
152
1.53
1.10
1.0
1.3
—
—
—
0
0
33
454
0.72
1.09
1.3
1.1
0.88
0.90
g/l
0.19
33
454
21
136
1.56
1.09
1.2
1.1
—
2.14
—
0
29
11
59
1.88
1.07
3.0
2.5
1.20
1.19
mmol/l
0.15
11
59
10
52
1.93
1.06
1.3
1.5
—
—
—
0
0
10
52
1.93
1.06
1.3
1.5
—
—
—
0
0
10
52
1.93
1.06
1.3
1.5
—
—
—
0
0
684
6615
1.17
1.06
3.8
3.7
1.35
1.27
mmol/l
1.64
652
6279
11
60
1.84
1.03
2.7
1.8
—
—
—
0
0
7
34
2.07
1.03
3.3
1.5
—
—
—
0
0
15
91
1.66
1.01
1.2
1.2
—
—
—
0
0
12
68
1.78
1.01
1.2
1.1
186.00
212.20
mg/l
0.42
12
55
9
49
1.85
0.98
5.0
3.8
—
—
—
0
0
5
23
2.18
0.98
1.0
1.2
—
—
—
0
0
5
23
2.18
0.98
1.0
1.2
—
—
—
0
0
6
28
2.15
0.91
1.0
1.1
—
—
—
0
0
11
63
1.76
0.90
1.1
2.1
30.27
32.70
pg
0.98
11
63
12
71
1.70
0.89
2.6
1.7
—
—
—
0
0
8
42
1.91
0.88
1.4
1.1
—
—
—
0
0
26
186
1.41
0.88
1.7
1.6
—
—
—
0
0
14
87
1.62
0.88
1.4
1.2
—
—
—
0
0
6
30
2.01
0.87
1.2
1.3
—
—
—
0
0
76
905
0.82
0.86
1.8
1.6
3.51
3.45
mmol/l
0.20
50
613
49
390
1.27
0.84
1.7
1.9
—
—
—
0
0
8
46
1.75
0.82
1.0
1.2
—
—
—
0
0
6
32
1.88
0.82
1.0
1.2
359.42
146.81
iu/ml
—
6
32
13
81
1.61
0.81
1.4
1.5
—
—
—
0
0
10
58
1.73
0.80
1.3
1.4
76.00
76.71
umol/l
—
10
58
6
33
1.82
0.79
3.2
1.6
—
—
—
0
0
0
25
0.00
0.79
0.0
1.8
—
103.09
—
0
25
49
396
1.25
0.76
1.5
1.5
9.01
8.03
u/l
0.28
39
323
59
488
1.22
0.75
1.4
1.5
—
—
—
0
0
5
24
2.09
0.74
3.2
1.6
73.40
55.23
ug/l
—
5
24
5
24
2.09
0.74
4.2
2.3
—
—
—
0
0
5
24
2.09
0.74
1.2
1.5
—
—
—
0
0
16
108
1.49
0.74
1.6
1.9
6.15
5.25
mmol/24h
0.62
16
96
39
308
1.28
0.73
1.5
1.4
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
20
142
1.42
0.73
4.8
3.2
0.33
0.33
iu/ml
0.02
11
64
13
84
1.56
0.72
1.3
1.6
—
—
—
0
0
46
563
0.81
0.71
1.5
1.4
—
—
—
0
0
26
195
1.34
0.70
1.7
2.4
3.49
5.15
umol/l
1.60
17
149
15
102
1.48
0.68
1.6
1.5
—
—
—
0
0
14
94
1.50
0.67
1.2
1.1
—
—
—
0
0
13
86
1.52
0.66
1.2
1.1
—
—
—
0
0
5
28
1.79
0.66
1.0
1.3
—
—
—
0
0
5
29
1.73
0.64
1.0
1.2
—
—
—
0
0
19
138
1.39
0.63
1.3
1.1
—
—
—
0
0
19
138
1.39
0.63
1.6
1.3
11.60
3.42
u/ml
—
10
67
8
49
1.64
0.62
1.0
1.8
—
—
—
0
0
10
63
1.59
0.62
1.0
1.1
—
69.00
—
0
5
10
63
1.59
0.62
1.3
1.1
—
—
—
0
0
14
96
1.47
0.61
1.2
1.1
—
—
—
0
0
152
1386
1.12
0.59
3.6
3.8
23.89
21.76
%
0.61
59
535
50
419
1.21
0.59
3.4
4.8
74.42
83.06
ng/l
0.30
43
390
8
53
1.51
0.58
2.3
3.2
—
—
—
0
0
39
319
1.23
0.58
1.8
2.0
1.63
6.61
iu/ml
2.34
11
68
53
448
1.20
0.57
3.6
4.8
3.65
17.26
ug/l
0.79
39
361
8
54
1.49
0.57
1.8
1.2
95.50
112.52
pmol/l
—
8
54
6
36
1.67
0.56
1.2
1.5
—
—
—
0
0
5
89
0.56
0.56
1.6
1.6
37.02
33.49
nmol/l
—
5
76
59
512
1.16
0.49
1.4
1.3
—
—
—
0
0
17
223
0.76
0.49
1.1
1.5
0.27
0.40
nmol/l
0.88
11
183
24
191
1.26
0.47
2.9
2.3
11.45
10.72
mg/l
0.29
24
178
33
273
1.22
0.46
1.3
1.5
0.01
0.27
iu/ml
—
5
42
7
51
1.38
0.44
3.1
2.8
546.71
677.24
u/ml
—
7
51
16
122
1.32
0.42
1.4
3.4
7.76
7.46
pmol/l
0.08
16
122
5
32
1.57
0.42
1.2
1.5
—
—
—
0
0
33
391
0.84
0.42
1.7
1.7
—
—
—
0
0
5
33
1.52
0.41
1.2
1.2
—
64.00
—
0
5
5
33
1.52
0.41
1.2
1.6
—
—
—
0
0
11
79
1.40
0.41
1.4
1.2
—
—
—
0
0
0
17
0.00
0.40
0.0
1.5
—
5.81
—
0
8
0
17
0.00
0.40
0.0
8.4
—
5.97
—
0
17
5
34
1.47
0.40
1.0
1.0
—
—
—
0
0
67
599
1.13
0.39
1.4
1.4
22.23
20.27
iu/l
0.20
52
509
50
438
1.15
0.39
1.5
1.4
170.08
248.68
miu/ml
0.93
21
226
185
1746
1.08
0.37
4.6
4.3
2.79
1.97
ug/l
0.30
168
1602
10
72
1.39
0.37
1.4
1.2
—
—
—
0
0
6
44
1.37
0.34
1.8
1.4
—
—
—
0
0
114
1061
1.09
0.33
3.1
2.7
0.61
0.73
ug/l
1.42
69
561
10
74
1.36
0.32
1.4
1.2
—
—
—
0
0
10
74
1.36
0.32
1.4
1.2
—
—
—
0
0
18
146
1.24
0.32
1.1
1.5
7813.27
7620.45
e6/l
0.01
11
102
298
2872
1.06
0.32
1.8
1.9
1.49
1.40
mmol/l
0.79
266
2524
12
92
1.31
0.32
1.0
1.1
—
—
—
0
0
43
380
1.14
0.32
2.1
1.7
3.46
3.49
mg/l
0.01
32
266
79
858
0.91
0.30
1.6
1.6
1063.26
1004.41
mu/l
0.22
63
728
7
57
1.23
0.29
1.0
1.2
—
—
—
0
0
17
205
0.83
0.28
2.2
3.5
75.33
577.46
u/ml
—
9
179
8
64
1.25
0.27
1.8
1.2
—
—
—
0
0
8
65
1.23
0.27
1.8
1.2
—
—
—
0
0
27
234
1.16
0.26
2.6
2.2
1.57
4.41
iu/l
—
8
104
21
178
1.18
0.26
1.7
1.8
—
—
—
0
0
12
95
1.27
0.26
2.2
1.6
—
—
—
0
0
5
75
0.66
0.26
1.0
1.2
—
209.23
—
0
13
9
73
1.24
0.25
1.3
2.0
—
—
—
0
0
9
73
1.24
0.25
1.4
1.2
—
—
—
0
0
112
1186
0.94
0.25
1.8
1.8
3.73
3.53
ratio
0.62
85
886
17
142
1.20
0.24
1.6
1.3
2.60
4.60
u/ml
—
10
57
20
232
0.86
0.23
1.3
1.1
0.15
2.09
u/ml
—
8
129
12
97
1.24
0.23
1.2
1.1
1.44
1.45
g/l
0.00
12
88
5
40
1.25
0.22
1.2
2.6
—
—
—
0
0
5
40
1.25
0.22
1.2
2.6
—
—
—
0
0
5
42
1.19
0.21
1.4
1.2
—
—
—
0
0
34
377
0.90
0.21
2.1
2.0
39.06
39.75
nmol/l
0.06
34
367
0
12
0.00
0.21
0.0
10.0
—
11.09
—
0
12
32
355
0.90
0.20
1.8
1.7
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
0.50
—
0
14
0
14
0.00
0.20
0.0
1.1
—
1.17
—
0
14
43
462
0.93
0.15
1.5
1.5
1.23
1.22
ratio
0.02
24
294
43
462
0.93
0.15
1.5
1.5
1.14
1.14
ratio
0.03
24
293
43
462
0.93
0.15
1.5
1.5
0.85
0.96
ratio
1.46
24
293
6
80
0.75
0.15
1.2
1.2
—
—
—
0
0
23
255
0.90
0.15
1.4
1.3
—
—
—
0
0
12
140
0.86
0.15
4.2
3.9
12.30
25.87
mg/l
—
6
102
9
82
1.10
0.15
6.3
4.4
12.93
388.06
u/ml
—
9
76
13
112
1.16
0.14
6.0
10.3
106.31
105.34
mmol/l
0.51
13
101
13
112
1.16
0.14
6.0
10.3
11.00
11.71
mmol/l
0.34
13
101
28
305
0.92
0.14
1.4
1.6
61.76
54.72
ug/l
0.48
28
305
181
1769
1.03
0.11
4.0
4.3
13.14
9.08
mg/mmol
0.65
121
1169
28
300
0.93
0.10
1.7
1.6
—
—
—
0
0
43
453
0.95
0.10
1.5
1.4
—
—
—
0
0
6
56
1.07
0.08
1.2
1.1
1585.17
1518.87
miu/ml
—
6
56
11
98
1.12
0.07
1.2
1.2
—
—
—
0
0
6
73
0.82
0.07
1.2
1.2
1.24
1.60
nmol/l
—
6
67
6
74
0.81
0.07
2.3
1.4
253.17
185.67
pmol/l
—
6
74
22
235
0.93
0.07
1.2
1.1
6.61
6.47
u/ml
0.01
11
142
7
81
0.86
0.07
1.0
1.5
—
—
—
0
0
16
172
0.93
0.06
1.2
1.1
0.26
0.33
u/ml
—
6
60
48
496
0.97
0.05
1.6
1.5
64.46
61.56
ug/l
0.15
41
426
12
112
1.07
0.03
1.6
1.5
7.54
7.17
mmol/l
0.17
12
100
25
258
0.97
0.02
1.2
1.2
3.70
3.51
u/ml
0.02
12
142
15
143
1.05
0.01
2.9
2.5
131.80
132.57
g/l
—
10
118
10
94
1.06
0.01
1.0
1.2
—
23.40
—
0
5
17
164
1.04
0.00
1.5
1.1
—
—
—
0
0
11
111
0.99
0.00
1.4
1.4
—
—
—
0
0
13
135
0.96
0.00
1.2
4.1
1.39
2.21
ratio
—
7
76
12
125
0.96
0.00
1.2
2.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
1.78
—
0
8
0
8
0.00
0.00
0.0
1.5
—
5.86
—
0
8
0
8
0.00
0.00
0.0
3.1
—
0.38
—
0
8
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
6
69
0.87
-0.00
1.0
1.1
315.83
282.84
mg/l
—
6
63
0
5
0.00
-0.00
0.0
6.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
11.00
—
0
6
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
8.7
—
—
—
0
0
0
6
0.00
-0.00
0.0
5.3
—
8.10
—
0
6
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: ST19_SUPERF_INJURY_NECK – Superficial injury of neck
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).